TitleGenColors Logo

Gene list

Applied filters:

COG category: Cell motility
Organism: Chromobacterium violaceum ATCC 12472, ATCC 12472
Gene type: CDS

Number of genes found: 186

Free access
Sort by:

 



# Chromobacterium violaceum ATCC 12472, ATCC 12472

>CV2859 probable methyl-accepting chemotaxis protein
MTITKRLLLTTVLALLAMLALGVQGLWKQQQANDRFDYMKINTFPSIHTL
DDAKEALADVRLTLARSVALSDPAAKKAEFAALADLDKRFDAALDKYEKD
LVSNDADRKLLQTDREDMKLYRQQRDKYLQLLQSNNVAEADKLMTGDMSN
EAKALNQALIDHIEFNYKLADQLSKDNAAAYTAAWWQSAILVASAVLVCG
WLSGHLFLNIRSSLEQTLSAMQAVRTTLDFRLRAPVARMDEIGKTATAFN
ELMARLQQSFKEIRHSVEEMEGAIVHMAESSGDIASSSVQQSESASAMAA
AVEQVTVSINHVADRAREANQQAREAGEIADRGSKVVLGTVDGISAVAES
VGEASERIGKLREDSVTIATVLSVIKDIADQTNLLALNAAIEAARAGEMG
RGFAVVADEVRKLAERTASSTTEISAVIDKMQQGTQAAVSGMQEVVTRVN
EEAEKARGASDAIQQIKTNSEHSMLLIGEISGSIVEQGSASNTIAQKVEQ
IAQMAEANSRASSDSAGSAQELRSQASNIQRTVAQYQV
>CV1677 probable methyl-accepting chemotaxis protein
MLLGLLLLLLPIGLAVLVGRNIIRTLGAEPDEVARGMRELSAGRLDFFLP
LRHGDDHSLAAHIRQMGERLSGVILQVKEDADAVANASTELNSASQGLSQ
GAARTSSDVEESSSAIDDIARCMFHMAGDANDAGCMADTASGQAAEGNRV
VQQTIAAMRQIAKRTDIIDDIAYQTNLLALNAAIEAARAGEHGRGFAVVA
DEVRKLAMRSQTAAKEIGKVAIDSVELAENAGQQLSDIVESSRQTLELVK
GISSEATTQAQRVGGINQAMQRLNQLSQDNAAASEELSAAAQEVAMRADS
LRRQMHYFQQGAQPPAD
>CV2992 conserved hypothetical protein
MDGLAWMDADPAIGFADAMSDAGARQPPPEDEPESAPAARDAAPLAAVVR
QDLPVAPAAVDQNAAAGDGADGKAQAGKPVDAAALSPALLPQTWQALMPR
QAPPPAAAEFAVDVGERLAPALDAAAKPADKALQAQLPEMALPREAAPRL
DGLAAVLPQIHPAEAGKPAESFSLALPPSQPESWSGKLQAALGERLQAMP
AQNMDRATLRLDPPSLGTLEISLRHQAGALTVELTASHGEVVRQLQGIGE
ALRQDLGGRQYTQVAVEVREGMPSGHGQGGRQGREQQAQQQPGRALSEQG
WQAAGGFQLDQG
>CV2766 probable transmembrane protein
MRNQGKFKLGVLLIGLAYSACAWAGLGRIHVRSNLGELLKADIEMTGVQP
TELDAVRVGLAGIETFQALNVDYASSLSSLRFALSPNTRGATIRVSSTQP
INDPYLRFVVEAKAPSGRSVREYTVLLDPATYTAQNIVQDVPSYADSDQA
SRYRQAEPAKLAPAAPRELTVRQGATLRSLAAKVKPKGASLRQTMAALAQ
ANPDAFADGDVNHPKPGSKLQVPSARKMRAMSASQVAGILGEPAPAAQAA
PAGGQSGASAAGKGGDVLKLAPGDGADNSKLNDLQQQINAREKALQDATT
RIAALEQQLKALQSSLQASGAKLEPIAQAAAPAPSSSPAAASAPHPVAAA
SAPKPMPKPVEKPHPKPPAHPAPPPAPSLMSRVLGYLPLIGGGVAGVGLL
ALLGIMIARRRNAAADAAGSAALSRNTVGGHGPSTVGGSNSFMSNFTQAA
GAIDAAEVDPVAEAEVYIAYGRDQQAEEILKDALQKDPSRHEVRMKLMEV
YAARPDVASFERLAKEMHAAFDGKGVMWAKAAALGRAIDPSNALYQMPEG
DAEPSPSAGGGEVIDLDQELFGEEAPAPIEAAPAPAEPAPAQEQEADPLA
ALFDTPPGGAGTAPETEAHSLDFDLDAMLSAETEAAEAKAPEPEANMLDF
DFNLEAAPAEEAKPAESSAGGLESLYEDMLAEEPQAAEAPPAPPEAKADG
VSVMDDPLATKLDLAKVYLDMGDREGAREVLQDLLSEAKGALKDEAQALF
DKIST
>CV2852 probable methyl-accepting chemotaxis protein
MEQAKDLAHSMNEMTLAGLTGMMITGTVGQRDVFLDQIRELSAVRDLRVI
RGDAVSKQFGPGSAGDKARPGDEIERAALRDGKPHIAIESTPQLGEHLRV
VYPALASANYLGKNCLACHQVADKTPLGVVSMRISLEKPYAAVDAFRTQS
ILFALFASLPMLAVVYLFIRRFVTRPLREMSQGLAELAKGEGDLTRRLPE
RSQDEIGVTARLFNQMLGTVAGLVRQVSDSAEAVAQSSRRLSDGAGQLAA
SSHRQNSQSQAAAEAVEQLAAHIGEIAGKAEHVSSGAEESLQRSEQGRQS
LHRLQREVGQVESAVQLMAQAESDLVNSTAVITHMTKEVREIAEQTNLLA
LNAAIEAARAGEQGRGFAVVADEVRKLAEKSARSASEIDAVTGSLNDKTD
AVRQAVSAGLQSLEASRHSTASVAEVLDAANQSVAEVRSGLRQIVEVTEQ
QRRSSQTVNANIDAIAGMARANDADIRETVGAAEELEALAKRLTDSVSRF
RV
>CV4156 probable methyl-accepting chemotaxis protein
MRSLRVKLIAFIALLLVVLGLVITVLVYTQMRNEIVRGVDNELGGTSKGY
SALVSSWYKSKVGVVIAANPLVGTPDPRQTLARLSQAGGFDMTYIGTAEH
VMIRSDMKPQPQGYDPVARPWYQQAAASGNPGVSDPYVDFDTKKLVVTFV
SPVKDGSALKAVVGGDIFIDDLVKTVLSVKLRGNGYAFLVDKGGKVIAHP
DASLTLKPLSEKVPELTADRLGKLAADTTMQEVSIGGESKLIEVQPVEGT
NWLLGVVTDESVVTGPLNTLLLTVVGIGALCVVILIPVASLLLSRMLAGL
GRLRNAMLEISQGEGDLTRRIQVTGQDEIAETATAFNRFIGQLQKMFIAV
KEEAERVTGGVESVTDTVDKVAHDSRQISDVSSSNAATLEEITVSISHIA
DAAREADGLVNHTGQVSSESAHGMQQISQEMNSTVDAVKGLSAMLSSLDQ
RSQQISGITNVIKDIADQTNLLALNAAIEAARAGEMGRGFAVVADEVRKL
AERTGQATVEISGMVSTIREETSQAVSNMQRTVSSVDGGVELTLGAVQRI
EQIQQAMQEVMAKMNEITLSTSEQHKATTMIAQSTEQINGRIVDSDDALQ
TVRDTLSELSQSATSMRQLFSSFRV
>CV2513 probable methyl-accepting chemotaxis protein
MGNRSKSLLVFAGLCLASAAALVWVSPWLGWLIPVLGGGGLLLFHGGGGE
APPPANQPSAAAPAASDDDGQLELLLQVIARWEGNLQLVIEQSVTGGNQL
AGTLTGIADGLHATIEAAGSAADDIGSGSLEQMVADASQRSREISSVLAE
IVGHRQQLIDEVSRLATYSGELLSMADQVGRISNQTNLLALNASIEAARA
GEFGRGFAVVADEVRKLSQQSEQTGKQMSEKVVEINGALEQTRQTTTSLG
AQDADRGNNALGLLDESVRDFSAAAEKLAQVNQRMQTEGSRVEKELHASL
IALQFQDRVSQIVQHVAQDLKQMQAHLEAVREARRRGEKGPEAHPREWLK
RLESTYTTLEQAALHQGGGGKPAASSGDVDFF
>CV3814 probable type II secretion system protein
MRISKLVVALSLIYSCNLLAAPQNDTVMLNFVNADIETVVKAIGEISGKN
FIIDPRVKGTVNIVSSRPVPRALSYQVLLSSLRLQGFSAVEGNGVIKIVP
EADAKLHAKASKRIPRGDGDRLITKVFALRNSNANQLVPVIRPLVSPNNT
VAAYPQANALIVTDYADNIQRIESIIESVESAAAGDTVVIPVLFGSAVEL
ANSLNKLMQEGGADGGKTTILADARANVLLVRADTPGKIGKVKSLLKVLD
QPSQAGSNVRVVYLKNAQASEVAKTLRLLLASEGSPVQTRSTINTATSTG
GSASLMPSTTGSGSGASAQNPVSSPDAGAAVAASSSSAPSGAGVGTMIQA
DSNSNALILNVPDPMYQNLRNVIDLLDKRRAQVYVEALVMEVTASRATKI
GVQWAANVHGNGLIGNSLPSPSKPLVPGGSGASDTPGTALGSLVSSLTGG
GLTAAIINTITVGGQQIPTLGLLAQALEQEAQGNLVASPQLVTMDNEKAK
IVIGQEIGVPTATYPAGTNGTSNAPYSTYDRKTVGFGLEITPQISEGGTI
RMKISQAADSIDQTTLSAAAGPTFNRRTLDTVVTVGDGGLVALGGLTQET
TSNAEDKVPLLGDIPVIGNLFKYQGKERKKTNLMIFIRPTIIRDEIGNRA
VAGERYGYVMEDAARNVGRKLPLGLNDQLKTPAAGSIHGALNALDTLNKS
EDNTKAKQ
>CV1011 probable methyl-accepting chemotaxis protein II
MKTFTVRRQFVLLAACALLGLGGLTLTAWQGLRTVMINGAMYHQMVIGKD
FINDLDPPTQQLISSFLLVNQLRNTNDASMRQQLANQLQKQRAVFYDGQR
KWGNSELPQAMRDMLTQKVKPPADAFFQEIDSHYLPALEAHDQLAINQSF
DRLSAQYDLNDQAMQPLIAKTMEMQKQMEGEAQRITSQTFAAVAAVSALV
LLLLVGSLVLIYRQLIRGLGGEPHEVARITGEVAAGRLDVEMPPAPPGSL
SDSVQQMCRQLLAIIAEVKNSSDGIACAAQQISSTAMALSQGASTSAAGL
QQSSASIEQVSASITQTSDNSRTTEAIAEKASDEATQGGEAVQQTVTAMR
QIAEKISIIDDIAYQTNLLALNAAIEAARAGKHGAGFAVVAAEVRKLAER
SQVAAQEIGELAERSVTVSEQAGRLLKEIVRSSGRTADLVQEIAAATREQ
AGGIGQISHAVQHLNHSTQQNAAASEELASTAEEMSHQAERLQQAMAFFR
LGAEAARASPPPAPPKPVAPGGAIRAASEPDELEDMFRF
>CV3001 hypothetical protein
MPKAKIVAPQEGARLQALDLRTLGRPIHLLPLFARALRQELEDFLERELN
RRYHAGFRIDALRQQLPAADERRWQWHALDDWRLGSHFDRGLLLGILDYR
FGARAGASDGELPAETETERRLGRTLAERLLPRLARAIHQLSRASLPDAS
RPQPLGYPDQAAWQLEVDLSDGDAKLGTLRLRLNAAAFDALLQNLSGQRP
RLLGNPDSANFAERVRIRLDARLLEQELPLGAVLDLRPGSVLPVAMQPHA
EVCAQGSPLFRAQVVERQGKLCLSGFADIE
>CV0713 probable methyl-accepting chemotaxis transducer
MRRYAFQIETALDPAQHRRNPAGAACADVGSGGAGHFSSLPGKPASMFKN
WSVKQKILVSVALILLIALAIAGTVSTRMFQSALTERLEQHELKATVEGI
RNELDASIALPLSQTRQLAANTYLLDWTAAGEPESGVGPWQRYAKALMQT
SGASIISWTSEATLNIYIDHGTVKADPKGNDKWLADFLASGRDSQFTLGS
ETGKQQVMMFVNVLANKGQAGHRAVAALGFDVTQMAERVRKMAVGERGQV
YVVDASGQVRLHRDPAAMQKKTLLADLPGLSAIAPQLLNKSGFNLAHFDG
PNGPTIAASSYMPNADWFVVVEMDANEVYGAVTRTIWWVAAVDAVVLLLS
LLVIWRVSGFISRPLVQLRDAMRALSSGHGDLTMRLPADSRDETGQVAAA
FNQFMEQLRGMFQQVREQSGQLHRSAGELARMTERLSAGSRHNADLSETT
AATIEQLSVSVSHIAGNCHGTAEAVQQAGALSSQSAEAVGRVSVEIGSVA
ESMDEVKTVMEELERRSAQVGSIAGVIKDIADQTNLLALNAAIEAARAGE
QGRGFAVVADEVRKLAERTSQATVEIDDMVGGMQQGSGQARERVAKTYGA
VQGGVELAEEAQRQISEIQSSMQLVVRQAAEIRDAASEQSKATEDMARTA
EQMSSQALQSDAEIGRAGQVVADLERLSQSLEGLVSRFKL
>CV2463 probable methyl-accepting chemotaxis protein
MARTLSLKRRLLLQTVSAIALVCILGTLLMNTLRQQMLDDRHDQVRTQVE
NAASLVAMHERQAAAGLVPEAEAQKMAMRELASLRFDGDEYFFTLDRNLK
WLSHGMNPKLVGKDMHGVKDGAGANIGALFEDAMRKGGGKGFVNYVWDKP
GASAPQPKLAYFQTTPRWGWVVGTGLYLDDINATLTRQLLSVGAQVLLFM
AVSLSLGWWVYRSVMRELGTEPSVAADIVREIAAGRLDREIEVDAGHQDS
LLAHIREMQGQLRQLVGDIMRDAEELGRLNADVVDGARMVAGNSQGQSEG
AAAMAASVEQLTVSINHIAQHASDARTVSQDSGQLSEAGSQVIARAVEEM
QGISATVDLTEAAISELASKTATISSIMQVIKDIADQTNLLALNAAIEAA
RAGETGRGFAVVADEVRKLSERTAKATEQTADMIAEIQASSDLSRRNMSD
TVARVKSGLELAEQGGELIQQLRGSAGQVVQVVNDISHALQEQGTASQDI
ARHVEQIAQVASGNAVAATQASESIQRIDEVTGNLRLSVAQFQV
>CV3133 probable flagellar protein FliJ
MGMAQSRLAESRSRLDQLDAFREEYRQRLVGGGGQGMSIVQYQDFRRFLA
RLDEAMIQQQQDVDRCAQRFVMERQAWQMEYKKLKAYEKLLQREQEREAR
QEAKRQQKQTDEFATRRFWDRTHGGDA
>CV0257 probable methyl-accepting chemotaxis protein
MDRQTSLAGQLAAIVGLVIAILLCASLFSLYQLWGSIRAFRDQVAADQQS
VQQVLIMQVDFKKQVQEWKDTLLRGQDPAKLAKYWGNFEKKEQQVRDEGN
ALAASATDPQARQLLQQFVAAHQKMGDDYRKGLDAYKQAGADFKVGDKQV
AGMDRPPTELLTQASELLAKRAKANAAAAESSADSALWRVGVAMAAGTVL
GLGFFLYYVNATIIRRAREVVANLTRLADGDFTRPFQPGRMDEIGRIAAC
SETVRTHLGALIGELLNAARQVGGTSQELGRSAQALAQGAETQNDAIAGN
AASLEEMATSVDTIADQTARISDDSRHSAQKTRDGLDEVARLRRQAETID
TVMGQVDQASQAFRDSTQAIGLLTAQIRDIAEQTNLLALNAAIEAARAGE
MGRGFAVVADEVRKLAENSAKAASEIKEVTEQLSQNAQSVGSTVQSGLDA
TRQSRDTMETVMANLQAANDSVQEASGGVGQIRDAISEQKSVCNSIAQRF
ETVAQMVADNSQAAGELHGAVQSLNGLSTRMQEMAGKFRL
>CV0826 hypothetical protein
MLVYYSLRQFWRHMRYTKPVQRGIDPVGEAEVFLAYGRTREAVRVLKDSL
KDDPDNLHAKVALLRAYSNARDSKAYVSLARDVHPQVQGQPVWHTIRENG
RELAPQEPLFSKR
>CV3139 probable protein-glutamate methylesterase
MPERAEADGCAGEPCLQGKNMALTSRERANKTPLEIVPSHNADVILPRQP
TKTPLASQTVIVIGSSTGGTEALRTLLTTLPANMPPILIAQHMPEMFTHS
FAQRLDSLCRLRVKEAEDNERLQAGTVYIAPGHSHLLIKSAPTIGYSTSL
NNGPAVNRHRPSVDVLFRSAANLVGKNSIGVILTGMGRDGANGMLEMRQA
GAWNIAQDEASCVVFGMPKEAIAIGATHEVLGLPSIAQRLVTLVHQRQPS
V
>CV3115 probable type-4 fimbrial biogenesis pily1-related protein
MTALLAASLWPQAAGAVTVSDNFTGGSAQLNWLVFGGACMTAGNGSGTIP
ACGSKDPSGNTQIGGYSGTLPDSNGNGALRLTNSAGSQSGAIVYNSLFPS
SSGLQATFTSYTYDGDSGGSARNGADGMSFFLLTAIPSAVGSFGGSLGYS
CSNVNSPYNGIIGGYLGLGMDEYGNFPNGGYYNDNTSSGPGAKPQNISLR
GAGSVAASSLGTQFGRSFSASMVQSVCRNGNYNGTSVMNYPFISIPGTSG
GVYQLPSSQPMANESATRRGQAVPISYKLKITPANLLSLWYSYNNGAYVP
VITNYDINNTAVSGPLPSQITFGFAASTGASRNVHEISCFQAQPFTQSAS
SSGLNSQQTTLIRTGTQQYVASYHADNWWGSLASYALQGNTSTGQVSVAS
TATWDSSCVLTGGSCATTGASNMNAQTSRAILSWSGSQGIPFQWANLTAG
QQSAISPDGNGSARVSYLRGARGNEVTTLGSGLFRDRDSVLGDLINSSPI
WVGPPQNNYQATWSDKLYPSASPAENATGAQTYPAYQSANATRTNVVYNG
GNDGMLHGFRSGANDANGNYVATNNDGQEVLAYLPAAVQANTVQYSNPTY
PHQYFVDATPVADDLFYNSAWHTWLIGGLGAGGQAIYMLDVSNPANFSET
NAASLVVSEINSGTLSCVNKATCGNDLGYTFGTPVIARFHNGQWGAVFGN
GYNSANGHAVIFIMLVNSSGAPSFYELDTGSGSANDPSGAGGKNGIYYTT
VADLDGDNTADYIYAGDLFGNVWRFDVTGSTPSSWSVSQFGKGAASPLFT
TQYTYCSSAQISAGSCTPSLQPITSKLLVTAIPTGNTSPRVLVSFGTGQK
IPFTTNSADVYAGGTQSLYGVWDWDMSGWNTLTGQSAYYSQAAPTGGLTV
RPSNLTAQTVAASYSSTLGSVQGYRALSNNAVCWQGVSSCSSYGWLLNLP
GSNEQVIYNPVSQLGTFTVNTTIPPNSNPSSCTVSSATGFTMSLNPKTGG
ATLRSYYANDSGNFNGISGSVIDGIAVNMAGSPSVVRFLGNYFAIGSSIS
GGPVATPPQINPAAFDLHARLNWIELR
>CV1010 probable chemotaxis protein
MPHTPPAYPAASADHRPPSSPPAEPAGEAVFLHPGDWHFGDSQTRIRTLL
GSCVSITLWHPQAKVGGMCHYLLAQRTPHRGESLSGRYGDEAMLLLLREI
LDTGLPLQEFQARLIGGASMLLSRERKLSHDVPSRNIQQARLMVKQLGLK
LLAEDLGGNCPRMVLFDVASGNVWIKQSQEAELEQAPHTRTRK
>CV0480 conserved hypothetical protein
MKTWRAQSGFSLVELMVAITIGLLLLTALVGIMVGGRKDYSTNTGQGMLQ
NAGATLSSVISQTARSAGFFGCSGATTSNALVAATGLLGNFNTPVVGYDA
VLASSTLTLTALNGSNDSTLTDWSPTLDGSLQGLVAKGSDVLVFSGQTNG
SVPVWVNAYASAGATALQTLSASNVAANNLLSVSNCGHASILQVSSVGSA
SGGSVINLRQALDTDFPVGSVAAPLSQTAYFVSQATGAQSALYQAVYDGT
ASSWQLTPVVPGVDALQVWYGVGGSPGVTTQYLPASQVSNWAQVNSLRIA
ALLEGPLGSAPATGKTGCANRTSWSVLGSTVVVPCDTRLRHVYTMTVSLR
NAGL
>CV3002 probable flagellar motor switch protein
MELNQDFDLDGILDGLDADAPSPAPAESAPAPRDMTPFLRKIPVKLTLEV
GSADISLADLCQISAGSVVELDKIAGEPLDIKVNGTVIGRAEVVVSGDNY
GLRVVELNDLQLDSLA
>CV3114 probable type-4 fimbrial biogenesis transmembrane protein
MIAALMMLIVITIIGIALMRSSGLLGKLAGNTREKGRAFEAAEATLQYAE
WWLNQGGNAGAAANCSGRQSTLQVCNNALSNPTATTSWGNAGYTYTPPFM
TASASGGGQTYYQSPQLYIQYLGLNAAGSGAIYQLTAIGYGGNAASVAVL
QSTYTLYSGTTNLGK
>CV4244 probable methyl-accepting chemotaxis transducer
MLSQFSIGQRIAALAGALLLAVGVVGGVGWWSMDKINRELTALFDQKIAF
RHQMDDLQRTMLHIRQDEKNIFISIGNPANSDQSIQTNKQLLDKHIADFR
SGVAKAKGMAMAADHQGEFDGMLEGIAGYEQGMGGLYQKIASGEIAAANI
GDAGIAPFKPKLYAARGALDKLSKLADDSAQQAETDLETSMARTQQGMLT
VLLLALLVGVALAWVIVRSITAPLRAMQDSMRHAAEHNDLTIAVDQTGRD
EVSETGRALAQLLANLRAFIGQTREDAKQVNDTAHALSEVSRRIADASRV
QTDASSSTAAAVEQMTVSINLVAEHAAEMASEAKSSMSAAVSGSETAGET
AGQMQEIARVIGRSETIISGLNQRSDEIGNIVDVIHDIAEQTNLLALNAA
IEAARAGEMGRGFAVVADEVRKLAERTAQATGEISEKIQAVQGDTSTAAA
SMREAAERVSSGVALSGQLSERLEQIRTLSSGLLDKTSEIAAAMREQSTA
SNEAAKNVERIANMGSENGQSVESSSAMASQLSGLAHSLDEAISRFRTA
>CV1013 probable methyl-accepting chemotaxis protein II
MTALARMRIQTKQALGYGAIIVLLLLCVAAALHGFSSTSGIIHDITQINN
VEARLAHQLLEQNQQIRIDIRNGLLTASPEEASRVAQAFQDSLRRYQDTE
QQLAQMFQRESSTQPRERELMTAIQNGSRIVHQDYLQALALISRQQGKQA
AQLLTGKGGQLNETISALAAYEDKLNEDLARQGEDTYADSRNRLLLLAGV
ALLASVAIGLLIRRDLLRTLGGEPQQVAELMRQVANGNLQCQIALRAGDQ
SSLAASIMQTIQTLGAILGEVRNGSESLSVAAQHIHSTSQMLAQSASQQA
SGLEETSASVQQMSNSINQTNDNARLTESMAEKASGEAAEGGQAVQQTIR
AMREIADKISIVDDIAYQTNLLALNAAIEAARAGEHGKGFAVVAAEVRKL
AERSQVAAQEISALARSSVELVDGAGSLLEEIVRSSRRTSDLVQEIAAAS
KEQAGGVGQISLAVQQLNQTTQQNASASEELAATAEEMNRQAENLHDLIG
FFHLGSLHAASPAPAAVHRPQAALPAAADHHGFMQF
>CV3320 probable methyl-accepting chemotaxis protein
MLSRLSIASKLLLLLLPFSLALVGLASILSLDRQQTLNELRRSDRLISIA
GGSSQLIHDLQTERGLSNGFLSGQAASLPPPLQAARANSDKSLAAFTAVS
GELGDSRLSERLGALNGQLQGLAQLRADVEKRGIAAPDAFSSYSKDIDAL
IGLIARLAQANNDGDLLRSTMALLNLQCEKEFAGRERGYVNGLLQAGVLN
QQSHAQAASLIAKQDACANQFKLIADDTLRGQKEALDGGDETRAVQALRA
KVMNQALGQPVGVPPAEWFQATTRRIDALKGEQDQLLQQMAQMVAVKVAA
ARSDLMLTLGGSALVILLLGSLGFAIYRGIHMPVQRLEALMTTMSQDFDL
RPRATIRGHDEISRMGHAFDHLVDAFAHTLNEVNRNAHTLVDAANSMLNI
AERAAKASETQSQSATEIAAAVEQMTAGIESVTSNTQQSLTLAQQMQRSV
HDGRERMGDTTSAMHQTSSVLDDAGNRIESLQRKSEDIRSIITAIREIAD
QTNLLALNAAIEAARAGEMGRGFAVVADEVRKLAERTGKETLDITALIED
IRGETQTAAHHMQEAQERMESGLQMVSRTVDDLEQIHSEAGHAASKSQDT
ATAMAEQTSASNEVATNISVIASLAEDNASLVQEVAKLSDRLNASAGELV
RLVDRFKHLAD
>CV3127 probable flagellar biosynthetic protein fliP
MKKKIVIALLSGGALLSPLLADAAAGLPLMTSTPAAGGGQNYSLSLQMLL
FMTALTFIPAMMLMMTAFTRIVIVLSLLRQALGTTQSPPNQVIVGLALFL
TLFVMGPTFDQVYAKAWVPFSDDKISFNQALDEGSKPMKAFMLRQTREKD
LAFFIEISQSPKPQSKEEVSMKTLIPAFAVSELKTAFQIGFMIFIPFMII
DLVVASILMAMGMMMVSPVTISLPFKMMLFVLVDGWTLLMGSLVQSFYTG
>CV0265 probable methyl-accepting chemotaxis protein
MFNTLTIAQRLAVMVCALLAIPVLVGWYGLHTQEGILGDFATTYNDRVVC
LKQLKIVGDGYAVGIVDNAQKLRNQSQTVAGFLANLQKAQLDVRQQWGDY
RATYLTPEEKRLADQAEAAMANANRSVDKLRQIVQSGDAAALQHYVDREM
YPALDPVSQRISALVDLQLRVAAEEFSQSQQRAAFSHAANIALIAVGVVV
GFLLAWVIVRGLLSELGGEPRDVVALAERIAEGDLDQKLAVKPDDHHSIV
ASMARMQSALIQLVRNMQDITLRLSNSATELAAASEQVATSAEEQTRAAS
SMSASVEQLSVSICSVNDTAADVAKDSVSSGELAHQGETIIDETLQTIGR
VAEQARSSQQQADLMGSRSQEIANVIQVIRDVAEQTNLLALNAAIEAARA
GEQGRGFAVVADEVRKLSERTAQSTTEISGSIRDLLDCSQHVVDNIHHTV
DQMETGLAQAGRAREAVSGISGNVDRVKASLATISISLNEQQQAGTSIAA
NVEQVAQMSEETSAAATQTAEAASQVEQMAGALQSAISRFRLPAGGQPQS
SDRTAQPLAATAWQA
>CV2765 probable transmembrane protein
MGDIRVSSRLGERLAAELPLLGGAFDKSEQLRVSILPDPSQGAAMKEQLS
LVASITHQLDRSTDGRRMLLLSSSQPITQARLSFRVEVVAGNVRAQKTYS
LALDGAAAQGSEQARAAAKPEPKSAPRQAAEHALDGKVYHVNKGDTLSAI
AMRVRGHARGEDVAGRLLRDNPDAFIRGDANRLLAGAELRYPASWAMRDA
VDREEGGRPEAAAKPGSMAKLLAEGHQADQAKSASSRTEAHPEAKPAAAP
AVKPEAKAVAKPAVKAASSPAALAAERRMRDLLMKQDQALKQTEQRAKAL
EEQIRALQQTKSKPEADEAPASPTARKQEADVSAKPAPAEPKPAIAKPEA
PAAKREEHPSPPVGFMPAASAPQAPPQLAQPVERKPEPAAQAKPQAERGV
AAEAMAALSDRDVLIKLGGAAAALGLVALLLMRRRRAAAEGGESAGHADG
GDQSATMQLKPLTSLMSSLKKGEGIDLDSVDVMAEVEVYLAYGRQDQALL
ILREGLDKEPQRQDLRYKLLEVLASQSDKAAFIEEAATAKRMFGKDSTMW
QRVCELGRAAAPDHPLFEREAGAEPPSASLTAAAPEPRPAVSAPPPGPAA
APAPPSVPPADPAPAAPPAAASAVVEEDAEKMELAKLYMEMGDKETAELL
MREAQHGR
>CV2603 probable type III secretion system ATP synthase
MRLPDIRLIENTLRERLTLAPAPPGQRSGVELFGRVTEIGPTLLKASLPG
ASLSELCRLEPSGIEAEVVAVTGDHVMLSPFKEPLGVTIGSRVRPSGSPH
QLRLGDFLLGRVVDGLGRPLDGDELPADSELRSLDGPAPNPLTRQLIDTP
LPLGVRAIDGLLTCGMGQRIGIFAAAGGGKSTLLGMICDGSLADVIVLAL
IGERGREVREFLEHTLSEEARSRSIVVVSTSDRPALERLKAAYTATAIAE
HFRDQGKNVLLMMDSLTRFARASREIGLAAGEPAAAGGYPPSFFARLPRL
LERAGPAETGSITGIYTVLVEGDNLNEPVADEVRSILDGHIVLSRKLAET
NHYPAIDIGASVSRIMGQIVSAEHRQQAGKLRRLMAAYKEIELLVRVGEY
QPGQDAEADEALERKDAIRQFLCQSVTEKNDFEETLEQLWQTVD
>CV2319 hypothetical protein
MDPISIAMGLATFAPDIIKWISGDSKASDAAQKVVDIAQQLTGTRTGGDA
LNAVRNNPTLAFQLQQEIDRNKMQLAQISQATALAEIQVDTTGTVAVNAT
MQAEARAEHWPTYSWRPFIGSRSPILGAGSRTSSSASL
>CV2002 hypothetical protein
MAGFTGNTPADRALAAGFNGGSVTESILHAWDWSSVPMVNMSNSSGVHYA
LGYHEEIVKAFDWNNAIGLGIMFWTSAAGATVANYGVAGPLPAVEPNTVL
TYPCEGSSGTATGSTMEIDNLYPGYPGNFAGPPILVQTSPSSKIKLTSAS
LTNADRAEIPYYFALVNPESDPKHVLKPYQALVVPQSNLMANTRYNANIT
GTVNGMPFSRNFTFKTGTGSDPDSWASYRSAN
>CV3540 probable fimbrial biogenesis and twitching motility protein
MDADHRGQEIMTSWRGRLAGWLLAFGVIAPAAADGSNPSEVARIRSQLAV
EYSRIGNLKSALDNANQAVQADPAYITGYLSRAYVLGLLQMDDKAEQDYQ
QALKLDPANPQVNNNYGLFLCEHGRPQDSLALFQKALANPLYDSPQSAYL
NLGRCSAKLGRTDQANDYLLSALRVAPNYAPALSELAEMQLGLGNAKLAA
FYFERLRSGGGMNGLGAAELWLGARIARKTGNAALERACGNELKNRFPDS
RETQLLLSGS
>CV3132 hypothetical protein
MTIIVNTPAANAGTQASPGSVASAGNSGSGAAGDLFASLLGIQMSTMGAM
LPELGDGGNGKSADDKPAAKDGQGDGTLQAALAMPMLTALQLQPQQAETK
TPVQDLLTQQTTAKVDPSLLLQTAKQGFNWQDGQQKLPDPETTAAQFLPL
QQLQQAQPQQAAHVQSNAGLPQLTLPQTLTDPNWGKALGEQMLSMVNLKM
DKAQIQLNPPQMGPIEVTLKMNGTDQAQVLFTAAVPATREALESNMHRLS
SMLSSSGIQLTDSQVSSGNSGQQQQAFQQRKGQHQPVIGEAEVVDALSAI
KTARGILSIFA
>CV3111 probable type-4 fimbrial pilin related signal peptide protein
MDKKQGFTLLELLIVMALLAIVLAFAVPAYQSTVSSNAVMSESNNLYGDI
LSARNEALKRGQVVLVCPSSDGANCNTVAPASTNWAGGWIVLQAVNNSCG
DTSGTVLRRQQAFGSGDSAVYSNSAYPSLCFNRMGYAPSSNVGMLTFNTP
ANQASSRRCVALAAVGHPQVLASGQTDSTGQYTCP
>CV3649 probable methyl-accepting chemotaxis protein with HAMP domain
MSTPIVRLMQRLSYPQRFAVIGVLFAAALLYLVYGLYRSNQDNIESTAKE
KVGVAYMRPLTAMLAQAQQGQEVAVRAALGNAQARNELPSAMQQLQGKWQ
ALQDANGRLGAELASDAAWKDASAAWDKLKATQSAQPTQWIAAYGNLSDK
LNNLIGVISDNSNLTLDPDIDTYYLMDAATAKLTTLISHLGEANAIASLA
EAGHPLDPAQRDRLVELRPLIAEVNDGLGSDIAKAVAYNAALKADMASQA
DKLAAALKGQLPAIDDAVGGKTGASGLKVAGHSADAAQTVAAYIDAGLGR
LDQLLQARIDRTASQRNSYIAIGVASMLLAIFLFHQLYLSITLQLGGEPR
YVQQVVEQLAAGRLDTRIHLRERDELSLLAAIRQMRNQLRETVSQLLETS
GEVTRAADAMAHSAQSISVGSAQQSEAAASMAAAIEQLSTSLSVCAEQSE
QADRLSTDAASRSSDGNRVIAATASTMDGIVRDVSSVSDTITDLGRQSES
IVGIVDVIRDVADQTNLLALNAAIEAARAGEMGRGFAVVADEVRKLAERT
ALSTTEISNIVNQIQNTAQKGNDSMQQGMKSIMDGQQRAREAGSSMDNIR
HCVDDVLDSIHQITSSLREQSSASQALALNVEQVSKMSEQNSMAVRDSAQ
TAGELQAISQRLTGLAGRFTV
>CV0780 hypothetical protein
MGRPLQAGLTLLEMMAALAIAAVGACLALPMLGQQMERQRLRGHAMALMG
SLEHARAEALRLNRPVYLCAANLKVNRELQGCLPRQAGSSQSWPEGVLVY
ADQGAANAYYDGGERLRLAMFDGDRVAVRAEERQLALTAEGRLQSSRPVR
FVLSGRSQCLALTVAANGRAWLAEVGDACA
>CV2594 probable type III secretion protein
MTLLSLPITKLPGNAPLGPIIPAGDLADYIEASEIIEQAREQAKSIIQDG
EKKIENLCEMYEEISEAAWQDGLKNLEQQAPALRQQAVANVVEWLIAEQE
LEHKIIERLEGQLCDILIKVFKEYYGQQNESQLLINLLRERVRALLDSEE
GVLYVCPEQYEELKQALISFPKLLIESDASIMAGKALLQTPLVILSLSLN
EQFDWAISRLFSHSHEMWQERLLDCNIPQQGELSLFPKDFIEARGGNFMS
VSASLGSAAEPVVDSSQG
>CV3876 probable flagellar protein
MAAITSSVGALDVQGIVSQLMAIERRPLNESQQRADQYNTQLSTVGKLSS
SLSALQTALTGLSSGRFLQVFKATVSDASMGAVSTTSGGSSGTYQIDVKN
LATSRQLVFDQVGTSTITDPKAAISGAPDSISFQVNGKTQTVTLRSKPDD
VVSLQTINDKINAAGIGINASVVQNGSQYKLVLGSVESGLDNQFKIVAGS
NSSDSGGTSGSTLAGLSQSPTAGTESRDASNASLTVNGVAISAGSNKVTS
AVAGVEIDLYKAGSFTVSLSPDSAGVAKNLQSFVDAYNQVIGDVKAARSG
ALKGNASILDIQGKLQQVLATPVAGVDPVNSIAYLSQAGISLQKDGTLKL
DQTAFNDAMKKDKQAVVNLFGNASNTGFAQRFNLEINGMLDPKGVIETSK
ATIRTKVSTETQLQSSLQSRLDTKQAQLIRQYTALNKTLAEMQSGSSSLF
NLISSK
>CV2646 probable methyl-accepting chemotaxis protein
MNPSEIKVDPRPKIVSSCAALWLAACGLLALLGGGLPGYLALSVLAGGCL
LIVWLLGAPPAPAASVDVVSEARQKILSELGLLGNGISDMSGAVERDVSQ
MQTILSDAIVKLVQGFSDIESMLREQQALAMKIVQHGEQGEEMGFDAFLQ
RTSHSMTEFVDNTVSTSKTAMVLVDRMHEIKQRVDAVEAALSDMAEITAQ
TNMLALNAAIEAARAGEAGRGFAVVADEVRKLSQRSSDFSGQIRQSIDLM
VQAIEHAKSEIFEMASRDMNFALDAKTQIEGMLSQLSRMNTDTGQAVDQL
SQIAGRVSDSVRSTVTALQFQDLVSPLVRNVNSRMQGFYQVGDSMRQMNG
KDGLDELEDMRLRLQQLLEKHQGCAAPQGVSAGDIDLF
>CV0414 conserved hypothetical protein
MYAVLGDIEFDLISYFDGLEQRGGSDYAEHARIGGKPVLQFVGDRLDEVR
IDLVLHAAYCQPDAELQRLHAARQAHQALALVLGNGDHKGHFVITELTST
GRQSDRSGNLLAVEAQLSLREFRGQAAPSPKPGLLGSVSGLPQAKLQQSL
AGAGFKPDLSGLSKALSQAKTMAVQARKVVNDVRELKDLARRDPLSALGR
VPGVLKDVQTAVPGIAQGVERLNQFIQPYSRLAESIKPLIPQFQAMGRQL
GALAETMQGCTLDNVADKLGKAEAVVRDIDKNWPTRDIEMAKLAAKAVLR
RILE
>CV1297 conserved hypothetical protein
MRPGKGSQRYRESDRNMKKLICRGLRGWLLALLLAMPLTSHALGCWNGSN
SSGNVTSTFNLPGNLFVSANAPVGTIIWQSSLQNLSLYCSQSIGENVYFW
VNPKRATLAPGLQIGIIFNGQTYTQSSGAIDTGIYVPRGGYVNTVLQYSI
VLLKTAGAPSSGSSSINQYSVFQLDGIGGINAAPGINFNQLINGSVTFTP
GGTCDLSANGQYTINLPTVASGQFPAVGSAMSRNAFTISAVNCSTGVRTA
TFRFSGTADSNNPVLFANTGGTARGVAINLGSSADGANIGANTTNNTRVV
NVQSQQAQLGLFVEYMRTANIVPGSLQTAVTIDMLYQ
>CV0899 probable methyl-accepting chemotaxis protein
MRLLGLAYPSGFPKNYNQSTEEWPAFARAIQRRNEGNAMKSLRSRLIAFN
ALLMALFGLVLVTIVFMQMRAEILEGLDNEFAASLKGQSSVVTTWLAEKK
QQIVAQTAVASEADALRFLKVGTKAGGFNVNYTGYADGRSLFSDDWVAPA
DYKVADRDWYKLAKDAGQPIVTDPYVDEATKKLTVTIAAPFNHNGAFAGV
VGGDVMVDTLVKSVLSLKVRGNGYAFIVDKKGTVIAHPQADLTLKPITSV
VPALTPDRLAQLVQNDKASDVDIGGKSMLISAQAIPGTSWVLALVSDRDE
ILAPLHTLLYTIGGLTLLVFALMIPFASLVIGKMLAGLVRLKAAMEDIAR
GQGDLTLRLKDDGQDEIAATARAFNTFVAQLGQLFRGLKGDAQGVVGGVQ
DASQLVADVAQSSRHISDVSSSNAATLEQITVSISHIADSARQADELASA
TGHNLAASADNMQRLSSGMENTVQSVRGLEEMLSSLDKRSQEISGITNVI
RDIADQTNLLALNAAIEAARAGEQGRGFAVVADEVRKLAERTAQATLEIS
NMVGAIREETGRAVGDVNNTVQAVDEGVGLTREAVDNIAAIRASMLEVVA
KMSEISNSTQEQHKATTLIAQSSEAINGHVLENDDVLQNVSSTLQGLAGS
AGKMDAEFNKFRL
>CV3000 probable flagellar hook-basal body complex protein
MAKLGQSAPAPIAAQEDAATGHSFSQAMVSAVRDVDQQNRLAAEKMTEVD
SGQSDDLVGAMLMSQEASLSFSMLMQVRNKVVGAVDDLIKMQL
>CV2984 probable flagellar protein flgJ
MDLPSEGAGFAEQFAGVRAEVERFIADGGSASAQQLSPEAWRVRQQLGAG
SVDLSAVPPDRQAFVEEMLPHAQAAAARLGVTPDLVLAHAALESGWGRKP
LTRGDGGNSHNLFGIKADARWRGEVAASLTTEFIHGQKQSRVESFRAYPD
YRAAFDDYADLLASNPRYRAALGVGGDARAFAEALARGGYATDPDYAGKL
AGLAGQFRKGMR
>CV2580 probable secreted protein EspA
MSTAISSISSFSNGQVDSVGKAGDGDNIDYLRAARNYSLLGQAIATMEEV
MLLFTELSNAKFAQMSKKMEVSRDAQEMANKVEAVLAGITDPKDTKKLPQ
DVLDYLKANGISVDSVENLEGDLSQADLTAVKSALESFSGRASDFVQQSQ
LKMQQLIQNFNTAVTMANSLQSMNAESTKSIAQAIR
>CV0484 probable type IV prepilin
MGVREDGGFTLVEMMVTIAVAVLLLTVAMPAWQVFVQNERLNSTRDQLIS
AMNQARSLSISNDDVVTICPYNAGSASSCGTSWSAGWAIFELPQGGASSV
RVQAQPLTLGSSPTINAATSGGASLSSISFNPRPPYVAVGQTGDFRLCDS
RGASYALSFNLQTTGYIQQPAKAGVTLAGAALTCP
>CV1912 probable methyl-accepting chemotaxis protein
MFGFKKAASKAEDAARMVRQLESVLDHADNLIMLCDTTRDNTIFYMNQTA
RDVLGRHREMMNQKFRAGVDVNRAHGHSIHQFHRDPEHNRRILADLASGK
IPQHTAMIPVGEVMFETKVFPIWDSANPSQLLCFMASFQDVSSEIRAQKL
QEQGNQRRDFLEARVNELSENMQAMSATIQNVAVQTASASESAELMLGEG
RKGAGIVSETSSGMKNVGGMVRDTADSLESLGQRSETIGQIVNVIKDIAD
QTNLLALNAAIEAARAGEMGRGFAVVADEVRKLAERTTKATQEIGDMIRD
IQNEVKQNVDAIERGRQQVDATENDFQRAEQALGIIVGEINNMRDFVVQI
ANAAEEQAATSQDIADKLAEIVRQS
>CV3826 probable type IV prepilin-like proteins leader peptide processing enzyme
MLDDMTWLLATHPAWLAGAALVFGLMVGSFLNVVIHRLPRMLEREFLADS
VEYLAEGGAPAALRLAAEQARHELDDGGYNLWRPASHCPACRAPVRPWHN
VPLLSYLLLHGRCGDCGEAISRRYPLVELLCGALYGFLAWKLGWGWPLAG
ALALTAVLLALAFIDFDTKLLPDGLTLPLLWGGLLFNLMTGLVPLSAAVL
GAVYGYMTLWLVSHAYKLVAGRHGMGGGDFKLLAALGAWLGWTMLPLIIL
LSSLVGAVCGIAMMSASRVGRGQEIPFGPYLSAAGWIALVWGPQIMNGYL
TWLSR
>CV1081 probable methyl-accepting chemotaxis protein
MKSIRSKIALLLALAMLVATLSTAVSAYFKFRDNLSAGVSAQLDLAIGGQ
QRFVTSWLEQRKQIIASAVRHGGEADPTLYLQQLAEAGGYAQIFVGDGDS
KGMVYSIPGKQKPSPDYDPASRAWFKAAKAQGGVIVTAPYRPASASIKDL
VITIAQALPAGNKVVGGDIAIGQLVKSVLSVSLPGNGFVFLMGKDGKLIA
YPKADTALKPLSELMPGMDAARIAGLLDKPELATVELDGASRLLRLSSVE
GSDWVLGVVVDSELRDAPLRQMMVSMALSLLAALAITQLLAGAYLRRLLR
GLFQVRDALREISQGEGDLTRRIAAEGRDEVAQMAEAFNQFVGRLNGMFR
ELRAEAEQLAQGVIAVGGDVARLAEDSHMLADISSSNAAAIEQVTVSISH
IADATRETDSLARDTGAHAQSSAEELQRISSEMASTSVSVGELSALLASL
QQRSQEISKITGVIRDIADQTNLLALNAAIEAARAGEQGRGFAVVADEVR
KLAERTGSATVEIGDMVQNILAETGRAVGNMDRTIGAVDGSAAQTEQARA
RLVEITEAMRQVVDKIGDVALSTGEQHNATTAMAQSTESINNKILDSDAA
LQSAQRTLSTLDGVARSMQQAFSRFKL
>CV2509 probable methyl-accepting chemotaxis transducer transmembrane protein
MTSFHNTQVHIKLAIGYGIILLLMLAILLVGIRGMVAMSANTNEIVSDRY
VKVSLSNDIMQNTLNNGRYVRNLLLLTEPAEIEKTKQSIAKLRDDNKQLL
QKLDRLIDTTRGRELYDKIVSARDNLNLKYGELYALLGKDHAQAVTYLLK
EFAPANNTLITALDEMGAFQAQQMKDLSHEAAASAESARNLMISIGVAAL
VVTVLLALAIIRSILRQLGGDPSYAMQVVSRVADGDLAVPIKLRPNDNSS
LLYSIRGMAHRLSDTLAEVSSMSESIGAASEQVASTASSLAQTASELASS
VEETSASVEEMASTVTQNADNARVTEGIASKSADSATESGKAVGDMVHAM
KEIASRITVINDIANKTDLLAINAAIEAARAGEHGKGFATVAVEVRKLAE
RSQVAAREIGDLAGRSVSVAERAGVQLQDMLPGIDQTASLVQEISAASRE
QRTGIDQINTAVSQISTGMQSSASSAEELSSTSEELSSAAMQLQDLMQQF
KLRSARNARKSVMMHSGGHGGQGGSGHKAAPPPSAHAFDEDFDEEVDDGK
FSKY
>CV1358 probable methyl-accepting chemotaxis protein IV
MEWFWRLYTVSEKTFWNTLSKKLCSFFFISLFQLLMVAYSYHALSDIRSS
LRGAGVSPQVMAGVEASIDSALYWTLGLWLLSFVFIAFMVWYLRYLIVRP
LRMIIQIFNEIGAGAGDLSREIPTITYDEIRDLSLSYNRFLLKMREIISN
VRLMTVRIAMDSAVTRRNVTESLGSARQQDDLAKQVRQASDDSTRGVGLV
TEQTEAISATTAENLQVARDSYQELRSVTDSIHDISRKVGHFNHTVEDLS
QRSASIKTIVDLIKDVSEQTNLLALNAAIEAARAGESGRGFAVVADEVRK
LAERVKTATDEISHNIDGMLGLVANTQQETEAITADTNQARDVISRASEH
FSKMMGDFEATSSSLSQIAATMHGFADSNQQVNRNVAEIHQLGQLVNGRL
GQTEKAATELTAAAEQVQELVSKFIIGDGAFDQAVNRARDVRDQVQQLLQ
DAQQGGLDLFDQRYQQIAGTAPAKYRTAYDAKLEKLLQPMLDGVVGQIPG
GKFCVAVDGNGYAPTHNSWYSKPPSGDPAKDLVESRDKRIFNDAAGLRAA
RNVQPFLLQTYSRDTGEVLSEVVLPLELRGRHWGALRVGFDPHALLARD
>CV3435 probable chemotaxis protein
MNHAEGMNSHQYYDKHFQITAVKVFPGEFHATNQSRLLVTLLGSCVAVCL
SDRISGVAGMNHFLLPEGSLDLGAGTSAARFGVNAMELLITDMQKLGAMR
NRLEAKIFGAGNVLDGMTVVKVGERNTNFIRSYLANEQIPILAEDLLGEC
ARKVYFFTATGKVLIKKLKKSGAAIKQEQPYRGRIVDQGEGAKTGDIDLF
I
>CV3374 conserved hypothetical protein
MFTTTQELSALGQSQFDKAVRLSSIVLAGAERFASLQLDLSRKLLNDNAE
TFKALSEVKDAKTLGELQSNLAQPALDQAFSAARNVYDAALVTQNELSSF
VEEQIAENSKALQSGLDRLSKNAPAGSDIAVAALKTLLNTSTAAFESVSK
TAKKVSAEIAEAGVEAATNSAKAASAAVSRSKKTASSAA
>CV1080 probable methyl-accepting chemotaxis protein
MRSIRHKLILLTAVSILVATISVTVIACLNIRNHAYDEAKREVTQVLQLQ
GGLVSEWLTVRKNLITASLSRAGDPQASYYLQQIAKGGGFNIIYAGHGDS
GEMFYSVPGRPKPSADYQPAQRPWYQQAKAQGGVIVTDPYKDSEPETKDK
LVITIADKAPGQEIVVGGDILIDKLVKSVLDIKLAGDGHAFLMTRQGKVI
AYPKPGQELRPISELIPGLDESRFQQLVASGDVAPLDIDGRTFLVTLKQV
ANTDWVMGVAADEEAVLAPVTQLIWLIAGGVVIVLLVLVALSSGYLTRLL
RGLIQVRDAMSEIAKGEGDLTRRIDIHGEDEVAQTAEAFNQFVGRLNGMF
RELRGEAEELAHGVIEVGGAVKQVASDSHRLADISSSNAAAIEEVTVSIS
HIAEATRETDSLARNTGEHSRESAGDMQRISSEMEQTSQSVSELSALLAS
LEQRSQEISKITNVISDIADQTNLLALNAAIEAARAGEQGRGFAVVADEV
RKLAERTGKATVEISEMVENILGETGKAVGNMQRTVSAVDTSVELTSQAR
GRLIAISDAMQKVIDKIGDVALSTSEQHNATTAMAQSTESINNQILDSDA
ALQGAMQTLESLKQLAHNMQGAFGRFKL
>CV2305 probable flagellar protein
MSSISASAGPLDVQSIVSQLIQADSQPLAQSRQRASTYQSELSVIGQVSS
ALSALQSAASTLQSGSFLQQFSATSSDSTVASVSTSSGGAAGTYVLNVSQ
LAKSRQLVFDQNPNGSAITDQNAAISGAPSSLSFSVGGASSTVQLGSNAS
LSSIANSINGAGIGVNASIVQYNNTYSLVLSSAQAGPGNAFSITAGGTDS
NNTSGNTLAGLQQSATAASESANAQSALMTVNGVNVSSDSNSVTSVVNGA
TINLEKTGQVTINMAQSTTNITNTLQTFINAYNQVITTTASATQSHTTVG
STPTNTDISGDLTSLQEHMASILGTPVKGVDATSSYAYLAQVGITQKADG
TLTLDSSAFNAALTANPSAVANLFGNSQNTGVANVFNTTINSLLGPNGLI
TSNQTNLNSKVTAEQQLQERLQNQLNNEQTSLLTEYSNLNSELAQMQQAS
SSMANLIA
>CV1524 probable methyl-accepting chemotaxis protein II
MAMSLAAVGIVMWLSGIDALPKSPLPREALPKLQAKSLAGLSLVVLVLAL
AFDKAKSKSFAKLETARAEAERAGEALARMMEQIGHSIRDASGASRQIAD
STGSMARTMAEQRERSEDMVVVAQQMAVVTSQNAEQSTAATLLAQNSGEA
AREGGKAMNQAVEQLGRAGEVIGHASNRLEDLGQRSAEVSGIVQLIRDIA
DQTNLLALNAAIEAARAGETGRGFAVVADEVRKLAERTQNATKDIESKIR
VIVDGTNQALVAMRDGNQQMRAGRDHAQEAQRKLAGIIDGAGELAGLLQQ
VSQAEASQNQGFSQFAGDIVAVGESSRSLSGETHNIAEAVRRLDEQMDKL
HQAISRQETPSADARREPAWR
>CV1960 hypothetical protein
MKRLLISAAIAALPGMAMADAKADEIARLKAQMQKLQQQMAELQKAVEAA
TAPAGGQKAAAAAGGEDANAELKERVANMELKVDKLNTASTDGPIAGLSV
TGYLDPTYIYNRNNNSSGFQFLNHQNVYAYSNSTFGDVYLDIKKTFGVGP
TAPSAEITIMPNRGSGNTLLDGGSGNNIINTAVINFPLSDTWTFNAGLMN
SFGGYEVQQSNQMLTLTHGLLYDFSDPGSYIGAGFNWSHDVWAWKFLLAN
EQYRTHANLANTGNNASTGNPQVKSNNTPTFTARVDYTWSSALDLGGSFN
AGRQTLLTGNACAGGFGYLCGSADPYSNYFFTEADASYTLGDIQYNAELD
YGQQQKAAWNGGSAQWYGVSLLGHRKWMTDSLGKMGATLRYDYLNNSKNG
GGGGGVALGSGGFDGVNGFGVDPACLASGAADCKGANRMALTAALLFFPT
DQFTLKFEYRHDWASQAVFQRNDGSMKKSNDMLGAQAVYTF
>CV1850 probable methyl-accepting chemotaxis transducer
MSLLQSIKVGPRLSASFAALLAILLAISASVWSGLSHIEQSAQAIVNDDA
SKQQAAAELDRHSQNAALLLLQIIATPERKQREPLYASMDDANRRAGDVM
QRLKALPWNAGQAGSLQRLAELRAAYAKAFSDTVDLVEANDPEALAKQYG
GQTRPALQALLAATAELSAAQQQHMNAEMGSVLALMSATRSLLLACSAAA
VLIGLLLAWRVTRSITRPLEHSVAVLDAMAQGDLRSRVQADGKDETAQML
RRMNAMQAELAALVREMRASGDMVASAAASTDGSASEVAGSVEKQQTEIH
QINGLVGAFSAKLDRAAATASQAQRQARNAAELADNGQQLIETASREIGL
IAGQIRGSAESVDALRQRANSMHGMIEAVTDIAEQTNMLALNAAIEAARA
GEMGRGFAVVADEVRNLAARTARATREINDVISAMDAQTSDAMGRIEQGQ
REMARGVALIGEIVEPLTELKRGATATVGELDRLATDIAEQVRESQSIAD
SVSAIAESADESLKASQDASRNSGKLREVSAALQAQMRRFAVDN
>CV0782 hypothetical protein
MSRTRQAGGALPLVMSLLAVLGLLVLSSSRQLAGEARLASNSQDRQRAET
QARQALLGAEQWVWRMDRRLGLDAVDPARLYGEGRLFPPSCDGIEGKGLC
EPMVPPHRRQVGGQSLLHPCGNSREYALEPGPSQTACPQRVRGGALNWAN
PRYVVELIDPRFGESAGDRLYRITVRAWGRHPQSEVTLQSWYRVGEGVAE
GRRLDWREVGE
>CV3866 probable methyl-accepting chemotaxis protein
MFYQLTVRQKLFAGFGSLLAMLLAVVIVAMFKMDNIQQKTRDITEDRYPK
VMLIDRITMTTLDIGRGVRNAIIAPDPQLIESEIAKVESLRASNTADMDA
LDKLMATPPERELLEKVKQTRAVLGQQYAPMYQLARTSKGAPTYLFLKQH
FAASNNIFMAALKDLAKYQEERMNKAVQDSQGTYSQARSLMVTVALLALA
LGAMAAWFISRLITAPLQRSAQLVHQIKQGDLSGADEPLPAARDEAINIA
RDIQDMRKGLREVVSSIQENAHNVSNAARELASMSEEVAGGAQRQSEATT
SAAATIEQLTVSINHVADNADQASGQARSAGELASRGGHNVQASVGQIGT
VSQSVASTSQQMQTLTEEVQRIGNIVTVIRDVADQTNLLALNAAIEAARA
GEMGRGFAVVADEVRKLAERTTSSAQEITQMIGSIQHNAHRVVDSMAGSL
TSVEAVSGSASEASNSMQEIENSTQSIVGTIASITSSLSEQRAASLTLAQ
NMEQVSQMAEQNSATVEELATTSSELNSLSQNLQHVTARFKL
>CV1701 probable flagellar basal-body rod protein flgB
MHLDKALSIHPEALRLRADRTRVLASNIANENTPGYQARDIDFKAALASA
AADSPLAFDDGGGDLLYRLPNHPSRDGNTVELSVEQAEFSQNVSEFQTSL
TFINMKLHGLAKVIAGQ
>CV0685 conserved hypothetical protein
MTAMLQKKVLFLALVGACGLAHAAGADTSNDPSSSTRSEISNNLSNTYGN
TNVNQTGTAYLEGISVYEVFDPKADAMATARVDDVQKNLGNKLNVTDPAN
AAMSGSVTGIQGNAGVNNASGFFNQQANNVAITSASGKKSGAAAAVSFEQ
LNDGNTYTFAQPLYGTSNKMDATMSNSVSNIQGNAGINNAAGAGNQQKND
VALSSASSAVLATASAGGTQVNHGIAVTTFLPINGTASITGSVNNVTGNV
GLNNAAGLSNQQVNSLSVAATH
>CV0395 probable methyl-accepting chemotaxis protein IV
MSSPRKPTPFLRSHLAWVLGAFNLLVLLSILDDYLFPPLAHHAISVLLMA
STLALTWWLWQKGGRIFLLLNTLTRQLGLACSGELHHRSTQTRAMGEVGQ
VAWQLNDFLDLVETYFKEINTCFQEISRGNFNRRPLSQGLPGILSSSLES
VNIAIQSMADNDGFVRRNRLSSQLAALNNPHLRQDLAGSQRDLAAISQAM
DQVARITRDNADGARVSLDSANELSGHLDTIAGSVSSMDTASQMLAQEWQ
GIETSLADISAIADQTNLLALNAAIEAARAGETGRGFAVVADEVRKLAER
SKSTAHQVQGVLESLSSRIGDMQAQASAAGGVAGEVQSSVDSFRQRFSSL
AEQSDLVLQQVSAVQQKSQTSLQKVGHVIYKQSAYHAIEEAQEAPPALEL
EAWLEGDGAALFGSAAQNLRPPLLQLRQQVDAALRAASQNGQLDEAAIVA
SMRAVEQASQKLQSGLEELGGR
>CV3128 probable Flagellar protein FliO
MASSPLWAATATAPAPVSAPSPSPFASLLQVILGLAVVLGAIVGVAWLFK
RLSGGMLGGAGRVRVVGGTMVGQKERVVIVELEGEWLVLGVTPQQVNLLS
KMPRPEGAESEPAEPAEPFARWLKAALDKSREAQRRRQDK
>CV0479 probable type-4 fimbrial biogenesis protein
MRRGQGRCAAGFTMLEVLIALLVLAMGVLAAIAVILNAERASGSAYLRQM
ANQYAYDMVDRMRANSAQVSAGNYDVASGTSLSTLQSDCATSACSAATMA
TYDKYQWLSDLQNNLPSGTGSVYQPANGGSTERVVQVWWTDGNAVSGGSL
QSVTVRTIM
>CV3450 probable chemotaxis protein CheA
MSEFGGMEELLQDFLMESTDLLSDVDNKLVELEKRPEDKALLNDIFRGFH
TIKGGAGFLNVIPMVNLCHRTENLFDKLRNGEMHITPEVMDVILDATGIV
RDMFGTLGQGLMPGDADARVLAALDAALAGEPVAAEVHHAEPAAAPAAVA
EAAPAPAGNGPDWNQLYQAVTPNAAAAPASAAPAPAAQAPRAEPAPAPAQ
PPAPAAAPKPPAPKPAPSKPSGGGGPVASGPQENTIRIDTVRLDMVLNLS
GEIGLTKNRLTTLRTEILQGNRDTNTLRSLDEAISQLDLLVGDLQNAVMK
TRMQPIGRLFQKYPRLARDLARQLGKEVELVLSGEETELDKTMIEDLNDP
LVHLVRNAVDHGIESPEDRIASGKKPQALVQLTAEQVGDHILIEITDDGK
GMNPDALRRKAIEKGLIDQETANSLDEKQCLQLIFLPGFSTKDQISSVSG
RGVGMDVVRTNIQKLNGRIDISSVPGEGTRISISLPLTLAILPVLVVRAC
NQPFAVPLAMVREIITIDGSAIQEVSGKPTIVVRDEILPLKTLAGLLGWE
PTQKPYFGVLMQSAEKSFILAIDSFVGRDDVVIKPLQNIRPKGVAGATLS
GDGSVVLVLDMEDLLASSESNNTQTRTTDMIAT
>CV1328 probable methyl-accepting chemotaxis protein
MLGGFSLLILLLCAVVLIAYNKLQTIQNNITEIKEDRYPKIVLSQRIALN
LLYISRGVRDGVLARDPQKVEQQIRNVEVLRANNRADLDKMEPMLSTPEG
RALFAKIRAAQDSQRPLFEPLYGLMRSHQTDAARDMLENQFAPTNNAFIS
ALLSLRDRQQSRLDKSMQEAMDSSQQAVAILLGTALASLLLAMAVALIIS
NLITSPLRRSADLVHQIKQGDLSGLSEPIPPARDEAMLIARDIQEMREGL
RQMVQSIQDNAHQVSDSARALSGMAQQVANGAQTQAEATTSAAASIEQLT
VSINQVADNSSEASEQAQAAGQLANRGGHEVLESVGKIRFVTTSVDETAR
QMNSLTKEVQQIGNIVTVIRDVADQTNLLALNAAIEAARAGETGRGFAVV
ADEVRKLAERTTTSAQEITKMIGSIQQGVGQVVSSMGQSLDCVEGVSGTA
EQASNSMREIETSADTIMRTIHSITGALTEQRSTSLSLAQDMEKVSRMAE
ENNATVQELATTSSQLNALSANLQSVATRFRL
>CV0999 probable flagella basal body P-ring formation protein flgA
MIGLCWLFAAGAAWGAGAQDLARLEHLANLFLKRELEMRAATWTLGQLDR
RLVVPACNTPKAEWAMPGVTTGSTFVAVSCPELGWSLRIPVRINEKRLGV
VLNRAMMAGETISGGDVRLVDISNPALAGNVLTDASQAVGQVLRSGAPAG
AWVRNFMVRAPYLVRSNQRVKVQAQGDGFSAEAEGTALGNAAQGDQISVR
LSTGRVVLGVVQADGSVAVVF
>CV1700 probable flagella basal body P-ring formation protein flgA
MAKFTKTRYISAGCLLLALVQAPQIALAASPAEQEVERQAQKLIRQRLAD
AGLDQADIRLQTLPPRDLPATCASPWQAEAGDSRAFSRMRFDLACPASGW
RGGVIVRAAVSARVAVAARDLPAGVALAPQDVAWARRPVGDPADLFGQAS
PPQGLASRTPLRQDQPLRRRQLQPPQWVKRGDAVSIVARQDGIEVTSAGE
ALANGRQGEVIRVRNTSSNKIINARVSAQGEVAPLE
>CV0482 conserved hypothetical protein
MSRTSLNTTWVYYMSPPGGFGFTSSPTATSTTDTVLNPCYGYLSLGTSLS
TVKSNCASVASSLGLSGTTVNGSQYMTVAATSDDASINDVLYSSGLNPVF
MTYGTVSPSNPYSYYSLNSYKTGSVTVSYSLMAPGGFSGWGTSPTNAGYV
PFTPQVLYAQRGWGYGGSQSYSAAATNVAMTNLGSPSASQLTSAYNSFSP
FLQPETNSTSTSEIKAAAGQSPIYALLKTAQTSFTSTSSSSGCTPQKYVV
LITDGLPTQDKSGYYWPPAGSAAATGYGVTASFNADGSLNIAGTNDQALL
DAISQIQTLASAGIKTYVIGLGAGVAPATNPTAAQTLTAMAVAGNTGSYY
PAVSPAAFSSALGSILVQIQKGSYDQASVALNSTTLSTNTQAFLASFNPS
DTPYSDWTGDLAAYALGTSGGLNVSTSASWSAQTQVDAFASGSGWQNTRL
IATWDAVNNKGVPFRWPATGVIGINSTQQSQLQPSDTKGSLRVNYLRGDA
SQEARNGGAFRNRSHLLGDIVDSGPVYVAKPDGPYIDSSYQTFISNNANR
TPMLYVGANDGMVHAFNASTGNEAFAFVPNGVFANLYQLTSTSYNSNHIY
FVDGSPQAGDVMFADGSWHSVLAGGLGGGGKTIYALDVTSPSSLTSETAL
ANAALWEFSDSGMGYSFGRPTIARLNGSNAFAVLFGNGYASSGNHAIFYA
VNPQTGATLAKIDLCSSVPAACSSSAPQGLSEVVAVNSSGNAGAAVDTVY
AGDLQGNLWAINVSSANPANWSVRLLFTATDSSGNHQPITSAPAATLNPN
FPKQKGMMVFFGTGQLLAQSDLTNTNTQAFYAIYDNMTITSLTPSNLLQQ
TETAITTSVSGFPSTTVSSSLYNWQSPNPPLNCVVGRTCPTLYGWYYTLS
FAGSGSRMLTNPQLFAGNVVYTTFSPSATPCTAGGSSFLMSSNYATGGPP
SQPFLDANGDGLVNSSDVYNQQPLSGVQLGSFFASTPAFVVSNQGGYTAS
ILVGGGNSSSRNNCANGKLSCTSSSPSQQYYSWSGWWQIL
>CV3438 probable methyl-accepting chemotaxis protein
MLATVLRELADGEVRTEFRVRPGDKDSLFACLADVVAHTLENLRVRNALD
VCTTNVMIADDNHQVVYANRAVLDMFQQAEADIRQELPQFSARTILGSSI
DSFHRNPSYQRGVLQQLTGTHRGTIKVGGRTFSLVLTPIRDGQNRKLGAV
VEWLDTTRDLELKAAEEARLAADRRAAAENARIRSALDVCTTNVMIADED
HRIIYTNQSVQKMFQQAEADIRRDIPRFSAGGLLGSNIDDFHKNPSYQRG
LLQQVRESHRSSISVGGRTFGLILTPILGAKGERLGDVVEWQDNTEMLRL
QREADLRAEKESKLAAENARIRSALDVCTTNVMIADESHHIVYANQSVLN
MFQQAEADIRRDIPRFSAAGLLGGKIDDFHKNPSYQHGLLQQARGTHRSS
IVVGGRTFGLILSPIFNDKGDRLGAVVEWQDNTEALRLKAEADARALEES
RVAGENARIRSALDNCTTNVMIADNDRRIIYMNHSVTDMLRGAESDLRKA
LPNFEVRRLIGSTMDEFHKNPAHQRDLLANLRSTYRAEIQVAGRTFSLVA
NPVFDADGERLGSVVEWKDRTAEVEIEREVSEIVRAASAGEFGKRIEVDG
KQGFFKVLGDGINQLLGVTSRGLNDIANVLGALAKGDLTKSIGADYDGLF
GQLKADSNATVEQLKEIIANIKDSTDAINTAAKEIAAGNSNLSSRTEQQA
ASLEETASSMEEITSTVRQNAENAKKANSLATGASDIAARGGKVVGDVVS
TMNEINESAKKIVDIISVIDGIAFQTNILALNAAVEAARAGEQGRGFAVV
ASEVRNLAQRSAAAAKEIKSLIGNSVDKVESGSRLVDEAGRTMNEIVVSI
RRVADIMSDISAASMEQSSGIEQVNLAVTQMDENTQKNAALVEEAAAAAE
SLEEQARYLADAVAVFKLDDKPSHGKPPAGKPAPRLGAAAVPQIALAGAL
AHKTSHHPGSYQVKPRAIEPIQPPGDGEDGWEEF
>CV2907 probable methyl-accepting chemotaxis transmembrane protein
MKLSTRLGILVLNAGLGLVVLAGVALYSLHDSQLEDRRSQIRILLTLAGQ
QVSHFQKLEQSGKLSRPEAQRRAIEAMSSLRDKGSYVFARGSDNLVLVHP
DKRKLGKNDPGEKLPDGRTLVQAYDDVLRDADFGFVQIRTRRPNGDVPLP
KLNAVMRIHGWNWTIGTGVFLDDVDQVFNRLALRLLLIGAAVLAVVIAMT
WLVARSIYAVIGGEPYDASRTALDIAAGDLTLSVKSEGRGSLMEAIATMQ
ESLRGMIQSLQRGATDLERAVGGLSGQVERINDAAHQSLLATQGTSREIE
SMAACSDQVSVCAGETESDSLRSCRLAGQGEKLVMQAADEIQLVSGQIAS
ASTLIGGLADRSREIDGIAGEIKEIADQTNLLALNAAIEAARAGESGRGF
AVVADEVRKLAERSAQATERIAGMVKRIQEDTGSVADSMSEVRPLVTRGV
ERAQEAAQALREINQGAEHTLEQIRSMAKVATEQAEAGHSVASNVASITR
MVDASQASVTEVSGNVEALSALAHQLKDSVAKFRL
>CV0095 probable methyl-accepting chemotaxis transducer
MLHQLSVKQKLLLGYGLLIAILAVIVATAVANLSAMQANRREITNNRYPK
AELCNKIVITTQEVSKLIRDAVLSDHPQDIESNISKVEALRAENTASLNE
LDKTLVSAKGRGILEQALKARSALSELYAPLYQLIRANKDQESKVFLQKR
FAPAIDAFSQKFNELKAYQDGKVKEAVEASNAAYSQAVSVVFTAAGVALV
VAIAIALFISNLVTSPLRKSVELVRHIQEGDLTGADEHFPPSRDEAMEIA
RNIQNMRQGLREVVSSIQDNANQVSDSAHQLASMAQQVATGAQRQSEATS
EAAATIEQLTVSINHVADNSDQASRQARDAGELAGRGGHAVQASVGKIQS
VSTAVAATSEEMRSLTGEVQRIGNIVTVIRDVADQTNLLALNAAIEAARA
GEMGRGFAVVADEVRKLAERTASSAQEITQMISAIQQGVEKVVGSMEQSL
SSVDAVSGSAREASDSMEEIEGSTRGIVGTIGNITSALGEQRTASLSLAQ
SMEQVSQMAESNSATVEELATTSSELNALSHNLQNVTARFRL
>CV1652 probable methyl-accepting chemotaxis protein
MFAAISAVSLLALAGAIAQIGRGLFRQVGGEPAMVAEVAHRVASGDLTVK
LEPRGGDDRSVLAAMQHMVSRLTGVIEQLRLDAEQLNATSSEVSASAQSL
SQSASQQAASLEETSASVEQIAATVSQNSESAHLTDTMASQAALLANCGG
EAVSRTVAAIRDISSRIDVIDDIAYQTNLLALNAAIEAAQAGSHGRGFTV
VAAQVRKLAERSQDAAREICALAGGSVDMAEQAGTALGEMLPAIRKTAEL
VQEIALASQEQSEGLQQINTAVCHLSLATQLSASTSEQLSAASDQLNAQA
DQLRRMIAYFRTRAAPA
>CV1580 probable two-component hybrid sensor-regulator protein
MLELLQGPAEQALDLSFYDADLLGAELLCAIADRLDRGGKLKIHAYHALL
AHGLMRLNLPARLVSSQPPSEARPWPRALALAGSAQSLDCILRIIECLPL
SDMAVFVAQHVQESQINLLDQLLKSRTDYAVEMPQNMAPVRPGTIYVAPP
GHHMRVGHGYVYLTRDRQIQFARPSIDVLFESLAGEYGAETLAALLCGFG
QDGADGCAALRAAGACVIVQDGGECAPARVMPDAARKAGHYDYVMKLSAI
ASVAAAAAAGPDAQPDGELLERFLSALVCHYGYDFRNYQRDSLKRRIHNL
MGQFNLGRFADFQRAVLTDVGLFERLCVELPVGVTSFFRHPEQLKLLRDE
ILPYLSSFPLIKLWSAGCSSGEEAYSLAIVLDELGLLDRSHLFATDFNPY
SLAQGSSALFPAQALEENRANYLAGGGTRLFDAYLSRNGRFLRVDDHLRQ
RILFYRHSLTDEGIFNEFQLIVCRNVLIYFDGELQRQVLRRFAQSLHAEG
FLVLGPQDGLHRAALEAGFELYRSGSHIYRLGRSVGS
>CV3813 probable type II secretion system protein
MMQAKFSTLLPFPFARANGVILLDGEAGRVLLLREDAKPAAWGEALRVHG
GQLSGVETLTAAQFEKRLSEHYASRDGAAAEMVDDIGQDLDLNQMVESLP
TVEDLLESEGDAPIIRMINALLTQALRDGASDIHIEAFEDRSVVRFRLDG
TLRDVVSPHRALHAAMVSRIKIMANLDIAEKRIPQDGRISLRLGGRPVDV
RVSTLPTSHGERVVLRLLDKENAKLDLATLGMAADTLASVDKLIRQPHGI
LLVTGPTGSGKTTTLYAALSRLDASHTNIMTVEDPVEYHLDGVGQTQVNA
RIDMTFAKALRAILRQDPDVVMIGEIRDLETAQIAVQASLTGHLVLATLH
TNDAASAVTRLTDMGVEPFLLASSLLGVMAQRLVRRVCPQCKAPHPVPLE
DAPEVVHYRPVGCPACGQSGYKGRYGIYELMLVDDTMQRLIHDRASEHRL
RDHADRHGMRSLRDDGMRWVKAGETSLEEILRVTRS
>CV3729 probable flagellar protein
MLAMNALSGYNPSVSSFDSLLPNLSSLLSSGLLLGSSSAASQASASSSKT
DPIQIELSTLGQLMSILGTFQSSLQQIYAPSIRFGGGTASSSNPAVASVS
TSSGAQNASYLLNVSQLAQAQSATTSFSLSDSGSTVVGSGSLTISTGSYA
YTSSTSATSFTASGSPVTISISNGTLSSIASSINGAGAGVVANVVQNASG
GYQLQISQASTGASNNFKITVSDNDGNNTDQSGLSRLAFDQTQAVGSGQN
LTQTQAALNASYTVNGASGSSASNAGIQLGSGVSANLLATGSSNITVNVD
FGQLNTSAQSLASAFNTALGAINSLLGNQVLPSQDPIARQLPQMLNQQAQ
KSYSNGSSLLTTLSQVGLNYQSPAQYGLGGTLNLNVASLQAAYNSDSSGT
ANLLYTVAQSLNALANSYTTQGNGTLVNETRALQAQQRTRQLVTNTRPTP
NTFPYNLQNLLSYPSSNSLLSSQQISGLAMYALVYSIGAPYALNSLLVGQ
GLGLSSSGFSAIA
>CV3285 probable methyl-accepting chemotaxis protein
MKIAHKAGLISALVLAVTLSTLSWLQYLSVADSIRSGKEQEVVQTSQVLA
EQIANWLNGKLAQIQLMSETIDANFSGERIVEVFQRPMLKKEFKLVFGGL
DTDGKKISNDSSWNPPPDWDARKRPWYPVAKAAAGVGLTDPYPDAASGEI
LISVVAKLTDKGAFKGAFGGDLSLKSVSEALNTATFNGAGYAFLLSADGK
IISHPDAKLNGKSVAELFGGAAPALGDKVQEIEAGGRKLMVAFHPLDRLQ
PAKWLVGVVLDEDKVMAEARQIGWRGFWGAVIGVVLSMVILSTLMQQILR
RPLQQLKLSLAELNSGNGDLTRRVDESSKDEFGEVARELNRFIAYLQRLI
GDIRQISTRVHHGAEQSAEEAQQSSGEASRLRQELEQLVAAIGQVAEASG
EMTSNAGAVAEAARLAHEETGSRMSLVTQSSQAIRRLADTLDQTSNSMNE
LAEFSKNIESIVRVITGVAEQTNLLALNAAIEAARAGEMGRGFAVVADEV
RKLASQTQQATQEIRSMIEQLQRGVGEAREKMDESRECASSTVKDAEQIS
EMLLRIQDVISDINARNSEIAGAVGRQSQMTQEINDSAGNIQHIGQRVSD
AAQVQLRHCNDTVSDVAEQDKMIARFRLE
>CV0873 probable methyl-accepting chemotaxis protein
MSIPEQAYQNDLAPLVAQIDAQLKQRDGELAGEKAGLAAALSRLAPLILG
PLALASALVVLIQLTLARRLRRQLAAMAQAADALGEGNLAVRLPDRGGDE
LAHAASRINRFLDHLAGLLDEVRRHAGANQDDSRRLQLLTRQSADASRLQ
TQKSQLSNEAAAEIAGHAERVGLHIEAALDCARGAAAATEDARRQGEHNA
ETMNLLAGRIATANQEMQTLGQALSAIGQISALIRDVADQTNLLALNAAI
EAARAGEAGRGFSVVADEVRKLSERTASATSGIFDSLRQMEQAKGALGEA
IAAAGRAGRDGQDAQLALDGALAAVDGALAGLGELMADIGAARERQTQAG
GNIRQHGHELASLAQHIEQQMREAEPLMEQLAESAGGLNRALAWFRLDAP
AGGAAERTMVPRGRARLSPA
>CV3321 probable methyl-accepting chemotaxis protein
MALAGLLALLLPIGASILLARDIIRTLGAEPDDVAQGMRELADGRLDFTL
PLAKRDTSSLAAHIRKMGEKLSTVILQVQADADAVANASLELNTASQNLS
TSACGTSADIEQTCVSVNDISRQMFHMADQASHTGDIASQAASQADSGNR
VVGEAILAMRHIAQRTEIIDDIAYQTNLLALNAAIEAARAGEVGKGFAVV
ADEVRKLAIRSQNAAREISQVATRSVRLAESAGASLDAIVAASHQTRELV
DGISRDAAAQARQVGNITTVMQGLSHLSQDNAATSEELSAAAHETAQRAD
SLRRQMEYFHQPRPD
>CV2583 probable secreted protein EspA
MSSINAQGGVQPASITTDEVIDNDHIEYLRAARNYSLLGQAIATMEEVML
LFTELSNAKFAQMSKKMEVSRDAQEMANKVEAVLAGITDPKDTKKLPQDV
LDYLKANGISVDSVENLEGDLSQADLTAVKSALESFSGRASDFVQQSQLK
MQQLIQNFNTAVTMANSLQSMNAESTKSIAQAIR
>CV1366 probable phasin
MSYNNEQLNKLSLTGIESTLRFAQIALDSTERLIKLQLEASKQSLEDHTK
AAKQLTEFKDSQEAINHLNKLATQSVDKLVSHSRNLYEVVSGAQSELSKL
VEDSVGQFNKSLISSIESVAKNAPAGSDATLNAVKTSVAAAAAAVNTFSK
AAQQVAEFTDSSVKAATSATADAVKNSAKRGATV
>CV1716 probable methyl-accepting chemotaxis protein
MSQAQIKWGRLSTRITLVAAAAISLAFAAMIALIARLNYTSALDTGYQLS
SEQADSYAKDAENMMSQGFLLPRHLADTVAGIKRAGRPDRKQTDNIIQEM
LDHAPQSIGLWMLWEPNAFDGDDNAFRFDWPRHDPTGRYQPYITRNAQGK
AQMDVMMSADRIKDFPKYKEHPETYKPDYEKPGWGDFYYVPKQRGRDTVT
EPFPYEVQGKMVLESSLAVVIKDAAGKMLGVSATDVALDQLQKRFGQIQP
GGNGYIRIVSEGGLYVVSPKAELLGKPVPKEDALFAHLADVKKGEDFVYE
DGGFTHFFHPIRIGETGQFWSLGISIPTSALTADARKAMLSAIAIGVVAL
ALILLLLAGVIRAQTRPLNRLADTMEQLAGGGGDLTVRIDIANRDEIGRT
ADAFNRLLDSLRDMFGKVREQSRQVSEAALTLSQSAGQVHDASAQQSDAA
TASAASVEQVTVGAQHIANTAQQAGDIARKTGALTEQSVAKVNRVTSEIQ
RMTDSMHALAERMNGLGERSNEVTTIVGVIKDIADQTNLLALNAAIEAAR
AGELGRGFAVVADEVRNLAGRTAEATVQITRIVDAISSETRQAVSDVQHS
SQQVDLSVGIAEEANQAMREVQDYNGQLVTSIVDIASATREQSSASVEIA
QNVERISSMAQGNNLVVREVSAAVNQLRGLAEGLERLVGHFKL
>CV4155 probable methyl-accepting chemotaxis transducer
MANAGLSLKTRLIGLMALVVVVVCGLGVVSVYNQRQVMLKDRQDKVRNLV
QSAVGLVSSYEKMVESGKIGEADAKRMLSKALSAMHYEKADYFFAYDADW
NYVAHGAKPELIGKNLAGVKDPNGVELKTLFQNAISSPGGGGYGEYVWSK
PGFDQPQPKISYVTTTPKWHWIVGTGIYLDDVAAAFRHELLWLGGVLAAA
LLVLLGMGGMILRNVLSQLGGDPQDTVAVVKRIAAGHLDEEVAVKEGDGD
SLMSAVGAMQRELERLVRDIIAGANQLSQVSSKVTGEAEAVGRGSEQQSA
AATAMAASIEQLTVSVNHISDRSQDARNLANESGTLSKSGGAVIAEAVSE
MRRINDAVDQTSGIITSLADKTQTISSIMQVIKDIADQTNLLALNAAIEA
ARAGEMGRGFAVVADEVRKLSERTAQATQEIASMIQDVQQGAEHSRHSME
EAVGRVKAGLDLAEQAGSEIARIQDSANGVVAVIGDISHALQEQSAASQA
IAQHVEQIAHSATSNASASQSASQAIHNMHQLAANLRQLVSRFSVRG
>CV3875 probable flagellar protein FliS
MLNSRMLKQFNQAYANDALKTAIYGASPVGIVVMLYEGAIKALQAADTAI
DNSRFDEKARMITKAVDILEGLRIALDLEQGSEAAVNLNDLYLYMKLRLA
KASLKNDKEILAEVRSLLETLLPAWQQVNRAGAAQAAGVEPQAGA
>CV3442 cheA, chemotaxis protein CheA
MAIDMSQFHQVFFDETEEHLAAMESLLLAMDVAHPEQEDLHAVFRAAHSI
KGGAATFGFSEMAELTHVLENLLDRVRKGAMGLTVEMVDAFLQAKDALQS
MLGAYKNGEEPDGGRQEEIQRQLEAIESQAPEAETAASPQDAAPAAEQLW
TLFLELTPADEHDIRPLLENLAAQGDLTIVQEGRTADELPWVAVFTSSLE
ADEVAESLAFMLPPERFRVSMDRGGEGGDEYGFFLSDDHVSPGRKGEGGV
SYVDEDGGFGLFEPLPGRETPGADAGSERLARMEQDGSFGLFEPLQAPAK
NEGRDVEGEGFGLFGGAPGVGAPAPGAAAQAEKPVAPARTSPDKGAAAGE
NSIRVNIEKVDMLLNLVGELVITQSMLMQSGSALDPVEHERLLNGISALQ
RNSRELQEAVMSIRMTPIAFVFNRFPRVVRDLASRLGKQVDLKMVGENTE
LDKGFIEKLSDPLTHLVRNSLDHGIESPDERVAKGKSPAGRLTLRAFHQG
GSIVIEVSDDGAGLSRERILAKARERGMPVSDNMTDAEVWGLIFEAGFST
AAEVTDVSGRGVGMDVVKRNIQNMGGRIEIDSMADVGTTMSIRLPLTLAI
MDGMSVRVGDEIYVLPLGFILESLQPETKAVKTVAGRGEVVHIRGEYLPI
VPLGRYFNVGKARQRADEGILVIVEASGSRVALLVDDLIGQQQFVVKNLE
TNYRKVDGLSGATILGDGQVALILDISTIARSNGGPRGSAAQMAAIAE
>CV2510 cheA1, chemotaxis protein CheA
MDLSKAREVFFEESRELCDGLESALLDPVAHPPGDETYNLLFRTAHTIKG
SAGIFGLDALVRFAHVMENVLERLRSGQVALSDDLITLLLACNDHLRRLL
DASAVSDQMAQRDLPEGEPLLAGLRRYQEGGASAGPAVAAGDAPVAAEAG
GGDVETGSPYWQLSLRFHPDTFRHGFDPLSFVRYLGGFGTLRDVTPVWRS
WPPPQLLDVTECFIGFDLALETEEGRQRIADTFEFIAEDSHIGILAPYAP
LADYLAEAEALGEPLEEQLERWLARGALTPDEAERIRNGDVTDPVEDAAP
DTQSAVPAAAQAPVGGAPARSGRGDSQYIRIEASKLDRLINRVGELVIAS
AGTKLIAQSRGDGELLESVAVINTLVESIRDDALTLRMVPVDEIFSRFPR
MVREVSKQLNKAIQLEIKGGDTEIDKSMVEKLTDPLMHIVRNAVDHGLES
AEKRRAAGKPEQGTVTLNAYHDAGSVVVEVKDDGGGINREKVLAKAIERG
LVAEGRLLSDQETLQLIFLPGFSTADAVSDLSGRGVGMDVVKRNIEALRG
EIEIQSQPGVGSTFRLRLPLTLAIIDGFRVEVNESALVMPLDMMIECVDM
PEGAMSQRARQVNLRGDWLPFVSLRELFGLPPAAHPEYIVIVHYGEHRAG
IVVDRLMGEVQAVIKPLGEIFKSLRGISGSTILGNGKPALVLDIPQLIHH
ACRRERRLIRQNAEALLGDKQ
>CV1014 cheA2, chemotaxis protein CheA
MDLEQALQTFLEESRELLDEMESILLDVEAEQTSAEQLNALFRTMHTIKG
SAGLFGLDAIVRFTHQAENLLDQLRDGKLKLDDELVGLLLRCHDHVKMLI
QALAAGDPLEALRDEPLEAALLAYLAAPQQAMPPPREEAPAAAALRTERW
LLSLRFGPDVLRNGLDPSSFIRYLSTLGTVERIRAIACRLPRGGDFDAET
NYLRFELLYRSDIGAQALHEVFEFVREDSELFILPLQAAAVSLREACATA
EPDEAQEVALAWRQFGAPDPSSGPENAPAAASDPAPGSPPPPAEADAPGP
AQPPPRQADAEPHPEIHAAAGETRGGRGGESRFIKVEAGKLDSLINLIGE
LVIAGASANLIARRSQQTQLVEATLGIANLIEQIRTGTLSMRMVQIGEIF
HRFPRVVRDVSRELGKEIQLRIVGAETELDKSMVEKLGDPLLHIVRNAID
HGIEPTAVRQANGKPAQGNLWLNAYHESGSVVIEVADDGGGLDRERILAK
ARERGLLGPDDEPPDSVVFQQIFEAGFSTAEQVTNLSGRGVGMDVVRRGI
EQLHGNVEIDSEAGLGTTFRIRLPLTLAIIDGFLVEVAASTFVLPLEAVI
ECIELPADLPENGVHDCINLRGELLPLLRLDHFFELPPVPAVRRNVVVVQ
YGDRKAGLVVDALQGEFQTVIKPLGALFNTLKAISGSTILGTGEVALILD
VPSLIQHACRRESERFALPPRADASPRPGSPLQGSTP
>CV2506 cheB1, protein-glutamate methylesterase
MSVSVLIVDDSAVVREVLSQMLSSAPDIEVLGAAPDPIFAMTRMKQRWPD
VIVLDIEMPRMDGLTFLRKIMDERPTPVIICSSLTEKGARITLDALAAGA
VAIITKPALNQRAFLLEAAKELVQEVRDAARAKMGVVKRISQGAAEHAPP
APKLTADVVLEAPSGLEKYRTTEKIIAIGTSTGGTQALEYLLPKLPATCP
GVAVVQHMPEKFTASFAERLNRLCRVEVKEAQTGDRLISGVALIAPGGKH
LLVKRNGAQYVADVKDGPLVSRHRPSVDVLFRSVAVCAGGNAIGVIMTGM
GDDGARGMREMHDAGARTVAQDEESCVVFGMPAEAINHGGVDEVMSLERI
AHMLAGIRG
>CV1009 cheB2, protein-glutamate methylesterase
MSIKVLIVDDSAVVRQVLSQVFTAASGIEVMDVANDPYMAMDKMKARWPD
VIVLDVEMPRMDGITFLKQLMASRPTPVVICSSLTQKGTDISMQAMAAGA
VEVIAKPVSGVKGFLEESSHELVMAVRSAAAARMNRVRVMPSASGNPLET
RPKLSADAILSAPTGSNVFATTERIIAIGTSTGGTQALEAVLTQLPRTCP
GLAIVQHMPEKFTRSFADRLNSLSQIEVKEADNGDRILPGRALIAPGGKH
MMVKRSGAYYQVEVVDGPLVSRHKPSVDVLFRSAAKFAGKNALGIIMTGM
GDDGAKGLKEMHDCGAKTIAQDEESCVVFGMPKEAIKLGAADEVMPLELI
AKAICR
>CV3436 cheB3, protein-glutamate methylesterase
MSAGTGRRIRVVVVDDSALVRSLLTAIVNEAPDMEVVATASDPIIAREKI
RETSPDVVTLDVEMPRMDGLEFLRRLMRLRPTPVLMISSLTDAGSETTLA
ALELGAVDFIHKPADDIARHMQEYAEEIREKLRVTAEARLRQPNRFRQPP
PARKTGPGAPLRKNALVFVGASTGGTEAIKDFLMGMPADGPPILIVQHMP
EHFTFTFAERLNKLCPMRVKEAEDGEAALAGVAYIAPGHSHMRVAPAGGG
GFRIALDQEEPVNRHRPAVDPLFDSAARHLGKNAIGVILTGMGKDGAEGL
LRMRHAGAVTFGQDEASCVVYGMPREAFRIGAVAHVLPLNRLAEKVVECL
QSQAERAIT
>CV2507 cheR1, probable chemotaxis protein methyltransferase
MHSSDPVLNDAEFARFRQFILSEAGIDLPASKRSLVQSRLSKRLRHLGLD
SYSAYWKLLSDPMGHAERQRAVNLLSTNETYFFREPQHFHWLEQQAQALQ
KQRPGGVRVWSAASSTGEEPYTIAMVLAESLGLAGNWKVCATDINTKVLA
AAKRGVYPLDRVRRTPPLLWQKYFLRGHDEYEGMVKVAPVLARRVEFSKL
NLLHCDRFQQNDFDIVFLRNVLIYFNEGTKRDVLSRVCSRMRDGGHLLIG
HSESLHKLDLPLAQEEPSRYRFEASRLKSGGAR
>CV3437 cheR2, chemotaxis protein methyltransferase
MRRLPEGGGARGRGMADETGLKFTRNDFKRVREMIYQRVGISLSDSKTHM
AYARLAKRVRSRGLRSFADYLDLLQHSEESEEWQGFINALTTNLTSFFRE
SHHFDILREHARRQRRPGETFRVWSSASSTGEEPYSIAITLLELWREAGA
GSFQLLASDIDTNVLQQAARGVYARERAEKVSADLLRRYFDKGVGGNEGM
IRLKRQVRDAVSFFQFNLVAPTWPDIGRFDAIFCRNVMIYFDKSTQAAIL
ERMAACLRPDGLLMLGHSENIVHLTDAFIGCGRTTYRLAHPDRGEGGG
>CV3693 cheR3, chemotaxis protein methyltransferase
MNKLPPVVLPKIEFNREFSFTDADFERIRKLIYKEAGISLNPSKKDMVYG
RLVRRIRELKLPGFAAYVDFLESIGGKREFEQFVNALTTNLTFFFREEHH
FPILAEHLKKKAAAGGELSIWCAAASTGEEPYSLAITALEAFPGVSKPNV
SVLATDLDTSVLETGRKGIYPADKIARLPAGHAVKYFDKQPDGSYQAKQA
LRNMITFQRLNLVESNWSVRKQFDAIFCRNVMIYFDRDTQFAVLKRFAPL
LKPDGLLFVGHSENFYFASDYFHLRGKTVYEHAKK
>CV3447 cheV1, chemotaxis protein CheV
MPSTDASLLASVDARTKLAGSNKMEILLFSLGTRETFGINVFKVREVSQT
PTITKTPNMPFGVEGVLSLRGNIIPVISLAKFIGHDHGGSKFDTMIVTEF
NKSTQAFLVDSVDRIIRVDWDKVRAPENIMAAAGTNQNLITAVTELENGK
LVSILDVEQILASVVGEPRLPDVPTAQLETDQYIFFVDDSVVARKEITGV
LEKMGIKFQQATNGREAWDRLQVLAGRNWADGECLHDYLKIILVDAEMPE
MDGYVLTKLIKSDQRFKGIPVIMHSSLSSNANRAMGSSVGVDSYVAKFDP
GVLAETLIPFLQR
>CV3446 cheV2, chemotaxis protein CheV
MSELLKKIDARTKLAGTNKLEILLFSLGHDQRTGRKEIFGINVFKVREVM
RTPEITSAPEMPSSVEGMVSLRGALVPVIDLAKYSGIVTSNRPEIMIVTE
YNGHTQGFLVEAVDTILRLDWSAMRVPPDMITNRMAGLVTAVTELDNGTL
VMMMDVEKVLAETSIIDDGHSFINIEPVKEERRIFFADDSAVARKQIERT
LEAMNIKYTSAINGMRGWEDLQKMAQQAEAAGRKLSDELHLVLTDVEMPE
MDGYMLTKMIKSDPRFAGIPVLMHSSLSGSSNQKLGESVGVDSYVSKFEP
QKLASKLRQMLKLEPSN
>CV3032 cheV3, chemotaxis protein CheV
MSDLLKKIDARTKLAGTNKLEILLFSLGDDQRTGRKEVFGINVFKVREVM
RTPEITTAPEMPASVEGMVSLRGALVPVIDLGKYTGIVTPKRPEIMIITE
YNGHTQGFLVETVDTILRLDWAAMRVPPDMITNRMAGLVTAVTELENGTL
VMMMDVEKVLAETCLSDETQNYISIEPVKEDRHIFFADDSAVARKQIERT
LEAMHIRYSSEMNGMRGWETLQKMAQQAEAAGHKLSDVLHLILTDVEMPE
MDGYMLTKMIKDDARFAGIPVLMHSSLSGMANKKLGESVGVDAYVSKDEP
QKLASKLREMLLLA
>CV2508 cheW1, signal transduction chemotaxis protein
MSERSDPAGAAQGGKFHCVTFILGEDLFGIQINFIREIIELDGITHVPMM
PNFVRGIINLRGSVVPVIDLSIRFGRGPTELKPSTCVAILSLPGLEGGYN
DVGILLDAVCEVLEIPDSDIDPSPTFGVSIRGDFIQGIATINERFAILLN
VQQALSVTELSAMAESVALQHFSDDAEVA
>CV3441 cheW2, purine-binding chemotaxis protein
MQLDNLSDAQARGAGTRELLVFTLGSEEYGLDILKVQEIRGYDTVTRIAN
APEFIKGVINLRGSIVPIVDLRLKFGLGEPHYNEFTVVIILNIGKRTVGI
VVDGVSDVIQLDQDSMRAPPEFGAAVDTAYIEGLGTVGEQMIIVVDIERL
MRSEEMALTDEVASRA
>CV1012 cheW3, signal transduction chemotaxis protein
MAALNILRRSEAAPEPGAQAEVRQFLTFQLAGETFAIGILRIREILEYIK
PTSVPLMPPFIRGVMNLRGAVVPVIDLSLRFGRDETAINRRTCIVIIEVE
HDEQWQLIGVLVDTVHEVLAIPDSEIEPPPQFGSKIRVDFISGMARIDNR
FVVMLDVDKVLSVGEMSLLSGLSRQEEAQEE
>CV3449 cheZ, chemotaxis protein CheZ
MFSSETNPSTMYEHIGQMTRKMHDALRDLGYDKSLEKVAETIPDAKDRLA
YIATLTENSAERVLNATDIAKPFQDKLESQAQALSERWEKLYANLLSVEE
FKRLAEETRQYLKDVPNQTQATNTQLLEIVMAQDFQDLTGQVIKKMMGMV
KILETELVNFLIEFSPDDKKGELNTSLLNGPVINPEGKTDVVTSQQQVDD
LLESLGF
>CV1295 ecpD, chaperone protein ecpD precursor
MKQAVWRGALALAIAGSAWTGAASAGVVVSGTRVVYKAEDREVTVKVNNP
GKEPSLVQVWADKGNEKSVPDTADAPFLIMPPIFRVDPAKGQTLRLTFTG
ADLPKERESVFWLNVLDVPPLPKAASEQRNFMQVAFRSRIKLFYRPVGLP
GTPDEAADKLSWSLLPQAGGKGYMLRASNQAAYHVSLNRAVLLVGKHEYE
TDGGMVPPGGSHDFALKDLKLKPEGALKLNYESINDYGAPVAHSISLAH
>CV2597 escC, type III secretion system EscC protein
MRASKWLGPGLVALTCAQAFAAIPWQSSAPFFLSTRGSKLADVLRDLGAN
YSVPVVVSKQVDEPFIGAIRSMPPEQALDQLARLHKLAWYYDGQAIYVYK
AQEVSSQLITPAYLQVSTLISQLQGSGILDRRYCRVRAVPASNAMEVHGV
PICLNRVEQLAKRIDEQKLNHEQNQEIIQLFPLKYATAADGSYSYRGQQV
AVPGVVSVLKDMAQGRTLPLKENQGQQPPTDRSLPMFSADPRQNAVIVRD
RKINMPLYASLIEQFDRKPALIEVSVMIIDVNSQDLSALGIDWSASASIG
GNGISFNSAGQQGSDNFSTVISNTGGFMVKLNALQQKAKAQILSRPSVVT
LDNTQAVLDRNITFYTKLLAEKVAKLESISTGSLLRVTPRLVDEGGQRNV
MLTLVIQDGRQAGTVSQHEPLPQTLNAEVSTQTLLKAGQSLLLGGFVQDE
HSEGESKIPLLGDIPLIGKLFRSTQKNSRSTVRLFLIKAEPAVQS
>CV3007 fhiA, fhiA protein
MMIINFMVVTKGAERISEVSARFTLDALPGKQMAIDADLNAGLINQEQAQ
QRRRDIATEADFYGAMDGASKFVRGDAIAGILILIINLFGGVAIGALMHN
LSMGDAFRQYALMTIGDGLVAQIPALLLSSAAAIIVTRINDEADMPQQVG
SQMLASPTVLMSAAGMMLVLAIIPGMPWPTFLGFAALLGYVAWRMHARRP
VAASTLNQAAVKSALQGESEIELEWSTLPYADTLGIALGYKLVALLDAGQ
GAPLTKRVKGVRQSLSEQMGLLLPTVNLRDDLRLKPSQYAIQISGNTVAE
AEVYADRLMAIPSPDVYGEVDGIPGIDPAFGMPVTWIALADKSKALGLGY
QVVDCASVMATHLNKVMRENLAELFRHDDVAALGERLAALAPKLAAALGQ
ALTPVQQLRVFRQLLQDNVSLKDIVPIATALLEASDASKDPIMLAAEVRC
ALKRQIVQAIIGPRDEIRAFNLSADLENLLLSALGQAQQTGKPQLDSFPI
DPNVLQQLQANMPVVRDQMKQLGQAPVLLVMPQIRPLLARYGRLFAPGLH
VLSYNEVPENRQVSLTGTLG
>CV1294 fimA, fimbrial subunit protein
MKQIVTAALIGLGVYSSGAMAADGKITVTGNIVAQTCNIAGTSGQNVTVT
LPTVGASALASSGQTAGATPFAINLSNCPSGLKNAQTRFEVGPTVNPTSG
NLLNSTGAGSATNVEVQLLNNNFNAINLSTNANSQVVPISGGSATMGYYA
QYIATGAAGAGSVNTSVQYSMTYQ
>CV1296 fimD, outer membrane usher protein precursor
MTHMTTRQPARRWDLSPLSLLIFGLFGGQATWADGPAAVAAAQDEVQFNP
VFINQNANGKKVDLSRFNQMGGAFPGNYRADVFANAAWIGRRDVQMKEQD
EGRVLACFNRAMLDDLGVDFSRLPQSAAVPGRDEPSRCVDIAAVVPGAFS
SFNSGDLRLDVSIPQKYLRAKARGYVAPEYWDAGAPFAGFLNYNANSYRY
DNGGAGKSTQYYLGANAGLNMGLWRFRYNGSLTQQDNGKGQRQRSYQSAS
AYTQRDVTAWSSVLTLGDYFTPSDMFSSAPFRGVQLSSDDRMLPESLQGY
APVVRGVAETNAKVSVRQNGNLIYENVVPPGEFSIDDLYNTGFSGDLEVT
VTEADGRVRKFVVPYASVPQLLREGQSRYAVTAGQWRDSTLNKRPNFVQA
TYQRGISNSLTLYGGLIAADRYQSALFGSGVNTPWGALALDVTQSWASDL
PFNASSSTMQGQSYRVTYSKLMEATRTNFTVAAYRFSTAGFLELRDYASL
INQVGVVYRAKNKFQLNADQPLGDGRGHVFLTGSTQDYWNQKGRDLTYQL
GYSNSFKSVSLNLSAGRTQDSTGRIVNQYMLSLSMPLGREPSSPLLSSSV
SGSSDRSGSAQVNLSGTTGELRNLSYNVYANANRDRAGANSSGGGGSVQY
ATSVATLTAGASASGSTSQANAGISGALVFHPGGVTAAQSLGESFAVVEA
PGAEGAAVSNTNGVRVNKSGYAVVSSLMPYRQNEITLDPKGMSQDVELQE
TSVQDAPRAGAIVMLKFNTQQGKPVIVALKRPDGSHLPVGATVSGGNGED
FLTMVGQGGRAFLRGMEGKQLMASWGSEAGQQCRFSYQLPQKQADAVCAP
Q
>CV3011 flaD, flagellin D
MLSLHTNIAALNTKSNMNSTQGALSTSMTRLGTGLRINSAMDDAAGLQIA
TRLDAQSRGMTVAMKNAQNGISMLQTAEGALNEVTNILQRMKDLGTEGAN
GTTTAADKTAMQAEFDQLGKELTNIMKNTSFGGEKLLQGGKVASALSFQI
GSAAEETMSVDLSGNMKSLDDSLGKVSANYEKTMTADEKAAADKAKRDKQ
ITAANGVLDATAKTAAEAAAKTAAGGKDQAAITAMASGTDAEKKAKADAQ
AQYDNGYLAEASKNADAKTAIDAAVANTEIGKSDTITTINAALDAVGTVR
SALGANANRLDHVINNLSNVNNNTLAAKGRIMDTDYANESSNMTAKQMLM
QASTSMLKQSGSMSSLAMSLLQ
>CV2888 flgB, flagellar basal-body rod protein flgB
MLDKIAHYFDFQQRALNLQAYRAEVIGSNVANAETPYYKAVDFDFKSALQ
AQVDKQGQLGLALTDARHIANQTGGAAGVQLQYRSAVQPSLDGNTVDMDI
ERGAFADNALQYQSTLAFLNKKISGLNSAIQGSGNGG
>CV2887 flgC1, flagellar basal-body rod protein flgC
MSLSNLFNISGSALSAQSMRLNVVASNLANAESATSSTGQPYKGRHVVFT
AVPVDAAQPQVAGVRVTSVVEDQSPPRLKYEPGNPLADERGYVTMPNVNV
VEEMADMIAASRAYQNNVEMMNTAKSLLQKTLQLGQ
>CV1702 flgC2, flagellar basal-body rod protein flgC
MSFRDISRIAGSAMTAQTVRLNTVASNIANADTASGAEQSAYRGRKPVFS
SQMQGEGMGVQVLDVVQNQEPVRKAHEPGNPLADADGNVFYSNVNAVEEM
TDMLSATRAFQTNVEVLAKVKTMQQDLLKLGDSA
>CV2886 flgD1, basal-body rod modification protein FlgD
MAPGASSMQAANGGASGNTGSATSAQSLQNNFLTLLTAQLNAQDPLNPMD
NSQLTSQMAQISQVSGLQSLNLTMQQLVASQNASQSMMATGMIGNNVLVA
GNTLASPAAGQTTQGGVMLSGPASSYQVSVLDKNGNVVDTVTVANPSKGL
NTFNWDGTDGKGHALPAGNYTFQVKVTQASAGGNTTATAYNNQKVQAVSW
LNGSPMLVLPGNQSVPLSAVAQMS
>CV1703 flgD2, basal-body rod modification protein FlgD
MSVEQAQARQFSASNQQGGEQKVAPAAGKNGAQPGNDMFMTLLLAQIRNQ
SPLDPADPSQFVSQLAQMSQMQSTQDMLKQLQSQGAMLRELQGVALGAQV
GKPVLLQTDRIRSDGQGELNGRLTLSGQEESATLILTDAAGQRTRIELGK
REAGASDFKIKLADYHLAAGNYQVELSTASGSKGLFELKAEVSGVRLPVN
GGEPVLSLAGLGDFPASSVSALLSA
>CV2885 flgE1, flagellar hook protein flgE
MGFQQGLSGINAASVQLDSIGNNVANANTVGFKSSRTEFGDLYAQSIFGT
AANSPGNGVSVLAVTANMSAGNTENTGRSLDLAINNNGFFIMNQPNGTQT
YSRDGQFQVNSQGYLVNSYGAYLQGYGVNTSGQPQVGPLQNLQITNTTIS
PQATSQISWPVQLNSNATVPVNSPVNPTDPTTYNWPSPTVVYDSLGNSHQ
VTLYYSLASTSATGNTWTVTPYVDGAPATIPGGGSGNTNFSVKFNNNGSL
ANTTPANVNLTFNTTNGSSTPQTVAINLTGSNQIAQNYGTGTITQNGSAP
GLLTGVSIASNGVVQATFSNSQTKTLGQVALATFVNPQGLLNLGGNQWQQ
SGNSGPATVNQPGTGNAGTLTAGSVEDSNVNLTNELVNMITAQRYYQANA
QTIKTQDTLIQTLLNI
>CV1704 flgE2, flagellar hook protein flgE
MSFEIALSGINAVNNQLGSVSDNIANSGTYGFKSGRVTFASAYAGSQAMG
VNANPNSQNIGRNGGLVNTGRALDAAIDGRGFYVSRSVAGAVSYSRVGIF
DTDKDGYLVDNYGGRVQGYAQSEGGALGALGDIQIPTGNIAAKPSDQLKY
SGNMSAGWAVQTVPFDKGVSQSFNHSTVSPVYDSLGNKHNLTQYFCKSAD
STITVHYQLDDKMLPATTDLKFDTAGKMTQPTAAVDLDLGTPAGANALKV
AVDYSGTTQFAGEPSTVRNAANGYPPGARTGVSLGENGEVIVSYSNDQKQ
VVARLAIANFANQGALTAASQTSWQESSASGPALLSPAGSNMAGKLVTSS
LEQSNVDVTSELVSLMTAQRNYQANTKVISTENQVMQALMQAV
>CV2884 flgF1, flagellar basal-body rod protein flgF
MDRVLFLAMTGAKHEAWQQATTANNLANVNTNAFKADLAAYRALPVVGDG
APTRTYVVDNTIGFDASQGSLQHTGNPSDFALGTPGFFAVQGADGQEAYT
RDGGYVLDATGLMRTHSGLLIMGDGGPITVPAGSQVQLGSDGSVMAVPQS
GANRAPQLVGQIKMVNPGPKDVYKGEDKLFHVNGGGTLPASADVKLVPET
LESSNVNSVEALVQMISHGRQYELNIKMMQTSQQNDQQAAQLLSMS
>CV1705 flgF2, flagellar basal-body rod protein FlgF
MDKLIYTAMSGAGRMLRAQQIHANNLANAETGGFRADIDTAVSQQVPGYG
YDARLLSQNAPTALSDRNGTVVETGRDLDIALQGDGFFAVSAPDGSEAYT
RAGSMVAGPDGTLSVNGHPVLGDGGPIRLPEGFLKVSVAADGTISVLNPD
DAAMQPVDKLKLVKPDPREVGKRPDGLIAARQGGPLPVDDSVRVQSGHLE
RSNVSAVEEMVSTMTLNRNFEMQMKLFNAASDMNEAGNRLVRG
>CV2883 flgG1, flagellar basal-body rod protein FlgG
MMRALYIAKTGMDTSQFQLDVVSNNLANVNTVGFKKSRGIFEDLYYQTLR
QPGGQLANGNANPTGLQVGTGAAAVASSRIFTQGPPQQTGQPLDLQIQGD
GFFRLLQPDGTTAYSRNGQFQRDANGNVVNPDGLPLNPNINIPATAQQIT
VSSAGVVQYTLAGSAAPQTAGTILLTTFINPQGLQSIGNNLYLQTAASGD
PQDGNPQTDDRGAIKSGFLESSNVNVTEELVNMITAQRSFEMNSRAVTTA
DQMLQKLSNL
>CV1706 flgG2, flagellar basal-body rod protein flgG
MNPALWISKTGIQAQDARLTAIANNLANVNTTGFKRDRMIFEDLFYQVEK
QPGSKVDDNNVSPSGVQMGNGTRLVGSQKVFTEGNITTTNQSLDVAIIGQ
GFLQVKMANGETGYTRAGQLSLSKDGVLQTAQGLPLEPEIRIPADATKIS
ISETGEVAVTRGSGTTPEAVDRIQLASFINPAGLLALGDNLFQKTDASGD
ANPGDPGNGALGKLKQGSLEGSNVQVVEEMVDMIAAQRTYEMNTKVLSAA
DNMLQQLGQSVR
>CV2882 flgH1, flagellar L-ring protein precursor flgH
MKSKLAITMVSALLLAACAVQEPPLVQGPTTAKPQPRPVGLPANGAIFQA
ASYRPMFQDAMPIQVGDTLQITIQENSSTSQSEQVTDTRTSGLSSNITAG
VKIPFLPSGLASGLGGTSFNSSGSANNTGKGNNQVATTFVSSITVTVTDV
LANGNLVVSGEKMVRINSDTESIRLSGVVNPRDVTPDRTVSSLKVADARI
EQQTKGNNRLYNEPGWLSKIFMSLLPI
>CV1707 flgH2, flagellar L-ring protein flgH
MTLARLAPLAALLLAACAQFQPPPPEPDPLPDLMRQQTSLPQGGGVFTAG
GSLSLTSDNRAFRPGDVLTVVLEETTQASKQAGTSFGKKSGAKIGPSLIG
NTTFNAQVGIDANRDFNGSSSSTQQNALAGSLTVVVHRVLPNGLLQVKGE
KQLTLNQGEEMLRVAGYVRVEDIDTDNRVSSLRIANARIGYSGSGALADA
NSPGWLMRFFASPLMPF
>CV2881 flgI1, flagellar P-ring protein precursor flgI
MKKWIVMASLLLAALPAMSAQRLKDIANIGGVRPNQLIGYGLVVGLDGSG
DKVTSSPFTGQAMINMLNQLGVQVPPGTKIDPKNVAAVTLTATLPPFSKR
GQMLDVTASSIGDAKSLRGGTLLLSPLKGADGQIYAMAQGNVVVGGAGAS
AGGSSTQINQLSVGRIPSGATVEREVQTALGDGEFIHLELQESDFTTANR
AVQAINKVFGGDTARAVDGRLIEVRAPFDSNQRVQFLSRMENIAVDPADL
SPLVIINARTGSIVMNQAVTLGSCAVSHGNLSVTVNNTPQVSQPNPLSGG
KTVVTNQADITINSTSGKVVGLKGGANLSQVVNALNALGATPQDLISILQ
AMKSAGSLKADLQII
>CV1708 flgI2, flagellar P-ring protein precursor flgI
MIFKQIRRLIAAALLAALSLPAAAQPLRQLVNVEGIRDNQLIGYGIVVGL
DGTGDNSQVKFSGQSVANMLKQFGLKMPEKTDTRVKNVAAVMVSASLPPG
YSRGQTIDVTVSSLGDAKSLRGGTLLLTQLKAANGEVYALAQGSVVIGGL
SAQGKSGSSVTVNTPTAGRIPNGASIEREIPSDFEQGDSIRLSLRRPSFE
TATNVVRAINRNYGKIATTRNATTIEVRAPGDPTERVAFVARLEKMNVDV
GAEIPRVVFNSRTGTVVISEGVTVRPAAVSHGSLRVVISESSQVSQPGPF
SNGTTQVVPDSRVQVEQGQGRMFKWPAGASLRAIIDTVNRTGATPDDVMA
ILQALDQAGAIDGELVVI
>CV2880 flgJ, flagellar protein flgJ
MLPNDMLSRQLAADPTGLQKLKAKASGDPKAAAKEAASQFEALLMNTMLK
TMRATKFDESEASNSMDTFQGLSDQQMVQALCSRGGIGLGDMIYRQIAKQ
SGFEPDAGKDGAALLSHGPALAARPIGERAAQAYRNASGVSEAGGSSPSQ
TVGGGNKSFVGGMLSHARDAAQQLGVAPECVVAHAALESGWGKRTIRNAD
GTDSHNLFGIKAGGDWQGKTTTIMTTEYVGGVAQKRQETFRSYGSYAEAF
TDYAKVLKSSSRYKNVLNQGQNVYGFAQGLQSGGYATDPRYARKLVDVAA
SLAQQVART
>CV2879 flgK1, flagellar hook-associated protein 1
MAIIGADVFGIGLSGLNVAQNALSVTSNNISNVNTPGYNAQYMTQAGRTP
VNAGFGYLGQGVDATSVMRTYNQYLVTQMQTAQTNSSYYTTQSQQLQQVA
NMIQNSTQSVSPAIQSFFGAMQTLTQQPNSTASRQAVLGMAQALATSMTS
MNSQLQQIQQGVNNQISSSVQSINALAQQIANLNQQIGAATGGNPNGAQP
NTLLDQRDQAVTQLNQLVGATINKNSDGSYNVSIGSGQPLVVGTTTFSLQ
TQQDPNNPANYLIGLAGPNNSLTMLPNNIMNGGQLSGLLNFRDGPLVQTQ
KQLGTLAINLSAAMNYQNSLGMDLNGNTPGAAIFQDLSKYVNNPQYAAGQ
FGVVMSDPSQLACASNLAPTGGAGGSGVTMSGVWSNLPGTYQTDINKTPP
VLDSVTQHPSYQLTGMTVTASATSPITMTATITGTNGGGPYNVVVDPTLP
NSYKLQTTAVPPVDVGIGFQLSGVPATNQTFTVGPATSTKNSGDSNNLRQ
MTAQQNINLVNGQSYQGFYSTMVASVGNATNTVNLQNQTAQTTLQEAQKN
NSNASGVNLDQEAANLIKYQQSYQACSKVIQIAQSTFSTILNALS
>CV1709 flgK2, flagellar hook-associated protein FlgK
MNTASQNIANQQTPGYSRQGVVLATQAPGAGDPLSAGYGVNVSNVRRFSD
DYKNLLQWQAASNVGSRAAAQPYFTQLEKVMGSKGSSLSDGFDQFFAALN
AASLDSNTMRDQVIRSADALAQRFNNLDGVLTSQLAAISEQRNATLTQIN
SATANLAALNEKLMSAKAQGINTSGLEDERDRQVDALSSLIEVRVVAQPD
GSKSISLKNGLPLVTGDSAATLSSEAQPDGSQQLKLAFGTEKYAMPGGDL
GGQLGGLNRFETENLRPVQAQVRTLAGELATRVNDQLAKGYDMNGQPGKP
LFQYDAGAAHGLLQTTGILSAELGFSADPAKPGNNDNLREVLKVKQQAFP
LAGIGNVTLGDAYSQMIGHLAISSQQNSSSLDTANVIRAEAEKNWQSTSG
VQRDEEAVSLIEYQKMYQANMKVIAVANQLFESTLAIL
>CV2878 flgL1, flagellar hook-associated protein 3
MRISSNTLYQSGVNNMSALQSDLLQLNMQIDTGKRVVTPADDPVAAARIE
LLNSSSGQNTQYGKNTQAVSSWLSLSDSTLQNVVNLMGAMKSQAIYANNS
SLSPTQLQQLQKTVAEGISELTGYANATDGNGNFLFSGNAVTTAPFSVNM
NASPPVTTYNGDNGQRSVQVSASRTMTISDPGNVVFGIPGGSPTATFDAL
ANLYDLLGQNPKPANFPSQISTIINQISNATQQLSIAQASVGSREQENET
LQGMSGSLDLQYNSAIGDLQNVDMAKAISNFTLTQTSLQYTQKTYAQVSQ
LSLFSYISG
>CV1710 flgL2, flagellar hook-associated protein 3
MRISSNQYQSVVLLAMQNSSAGMSELLQKMSSGQSMLVPSENPIASVRLL
RLQREEASLQQYRDNIGALKSQLTKNETLLDGISANLRDARDLLVAAANQ
PPTDDLKAMASPLVSLRDSILYAANTKDSEGRYMFSGSAVNNAAIVVDDT
QPAGSRYRYNGNGDRQRVTVGEGVTEASNVTLESMAPLLNQLDKAIATLQ
SPTLDSKDPAVGATIREVMGGVDTALDRVGGTISELGGAQNVLKTLDGNH
DSLSLANQESIIELGSLDYGTAYIAMNNLSMALQTSQKAYGKVSQLTLFD
VI
>CV1000 flgM, negative regulator of flagellin synthesis
MKIDNSGKLSGTYSTQSKPSPRASSSSSSSASAKDDSVKIDSLASKLSAI
GNDPSAQQPSFDAAKVEQIKSAIANGSFSINADKIADGLISSAQELLNR
>CV1025 flhA, flagellar biosynthesis protein flhA
MDSILQILRTMKITQLAGPLLIILILMMMILPLPPVLLDIFFTFNIAVSV
IVLLVGINVRKPLDFSSFPSVLLITTMLRLSLNVASSRVVLLEGHTGPDA
AGKVIESFSHFLVGGNVAIGIVVFIIITIINFVVITKGAGRIAEVSARFT
LDAMPGKQMAIDADLNAGLIGEDEARKRRSTIAEEANFFGAMDGASKYVR
GDAMAGILIILINVIGGLIVGVVQHDLPVGQAAETYTLLSIGDGLVAQIP
ALIISTAAGIVVTRVGTDQDMSEQFLGQLFTKPQVLYITSAVIGMIGLIP
NMPHFAFLLIAGSLLALARGMERRNRLRREKELQAAVQPAAAPEQQAAEV
GWHDVQHVDQLGMEVGYRLIPLVDRTQDGELLRRIRGIRKKIAQDLGFLV
PPVHIRDNLEIKPNAYRILLKGVELGKGEAFIGQFLAINPGMVSKEIAGA
ATTDPAFGLPAVWIDAGKREEAQSLGYTVVDASTVVATHISNLLQTHSAE
LLGREEVQALIDHQAKESPKLIEDLVPKVVPVSILQKVLQQLLSEGIHIR
DFRTIVETLADHVPQNQDIDELTSAVRTALSRVIVQQLFPGEAELPLMTL
EPALENVLMQAVQSKAGGGLEPGLAENLLSSAAQQTEQVEIQGYNPVLLT
APGLRPLLARFLRRALPQLRVISHNEIPDNKSIRIIAVIGGSKG
>CV1026 flhB1, flagellar biosynthetic protein flhB
MAEDSDLERTEPASAKRLSMAREDGNIPRSKELSTFAVTMTGVALLMAMG
GQLGHALGEIMRHLFTFDQATVQNTEPALIRFKESLFQALGALAPFFGGL
ALAALLAPMLVGGWNMTFKALEPNFGKLNPLPGIKRLFSLNAATEGLKAI
LKSLLIGGIATWYIWRERGEIIGLLAMPLEAGILKMTDLMIRTFFIVTSA
LILLVALDVPYQLWSYYKKLRMTKEEVKQEYKEAEGSPEVKGRIRQMQRE
AARKRMMQEVPKANVIVTNPTHFAVALKYDDTMRAPQVVAKGSLILAEKI
IDTGKESRVPIMRSPRFARALYFHAELGQDIPAQLYAAAAQVLAYVFQLR
QYQSVGGVAPVYPDQLDVPDELDPYSKRPQDSAPEESR
>CV3006 flhB2, flagellar biosynthetic protein flhB
MAEARQDDKTEKATPQRLRKAREQGQVPRSKDLAAALGLLLALKMMFWLA
PGWLDDFRQLFALAFASLSGQGALENSLSKLFGGTLLLLIKMLAPLAVIP
LTMLLLSLFPGGWVFVLNQISPKFERMNPLAHLSRLASPKHASEIGKSIA
KALVLGWLLYRVASDALHDFFALHSMPLLPTLAGAADLLLSCLLKLAAVF
LLFALADLPLQVFLFLKQQRMSKQEIKEEHKNTEGRPEVRQRIRQLQQQM
AQRGVRKALPGADVIIVNPSHYAVALKYDENRAEAPFIVAKGVDEMALYI
RQLAEEMKLTVLPLPPLARAVYHTTQVNQQIPAPLYRAVAQVLTYVLQLK
AFQAGSRRSRPTLPDLPVPRELSDPEPAS
>CV1024 flhF, flagellar biosynthetic protein FlhF
MVVKKFFGKTTRDALRQVREELGADALILSNRPTMGGGVEIMAVADADVA
NLASTLSTSSSKHPPRNAPPAVNRPQQPAPIPQANGSAMNRAIARTYAMP
VEPLESPAPPRLDAAPPRVEPTYAPPQPVAQPLMQPAAQPIPRAAPRPPA
PEPAAPHANGEEQEQMAQELRQIGDEIKLLRSLLQSQLASFAWSDMEGKA
PNRLELFKHLLAMGFSAQLIRQLIEKMPAQYQAEVAVKWARSALAHNLKC
ADADREVMDRGGIFALVGPTGVGKTTTVAKLAARATMRFGAQHVALITTD
SYRIGAQDQLRIYGKILGVPVFSIQNEGDLQLTLADLSNRHIVFIDTVGM
GQRDARVLAQIDMLRTAGRPIERLLLLAANTDGHTLEDVVKRYRGDGLAG
CILSKIDEAVAQGPSLDVIIRNRLKLYYVTNGQRVPEDLHSANAAFLVDR
AMRAQQIASPFALQADEMSIMQAAQAGWL
>CV3879 fliC1, flagellin
MAITVNTNTSSLQAQLNLNGSQMALSRSLQRLSSGLRINSAKDDAAGLAI
SQTLTSAIRGNNQAVNNANDGISVGQTAEGALGQIANNLQRIREIAVQAS
NGSVSNTNRSQLQNEVDQLTQEISRIVQTTQFNGTSLLSGSAVLTFQVGS
SGASSNQVSVSSVDMTSAGVLCSYNSSLTNTGTISVLSQGSASAVLSSLD
HDIAAISNVRSTWGSVQNRFDAVVANLQNYVQNLTAANSRILDVDFASET
ANLTKNQILQQAGSSILKQANSLPQAALTLLQ
>CV2495 fliC2, flagellin
MALTVNTNLASLAGQYQLNKTHNATKQTLAQLSSGSMLNSAADNAANLAI
AQQLQAQINGSNQAINNTNDGVSMLQTADSALSQLQDNTQQIQDLAIQAG
NGALNASNRQALQQQVDQLTQSNSQIIQSTQFNGTQLLNNSNASTFQVGP
NGTASNQISVPGIDLTGAPASGGLNSYNANLAATKTIDITTQANALAAQQ
SATSDLNTIGSQRATLGAVSNSFDAVVNNLQNSSLNTAAAQSRISDTDFA
AATARLTAQQILGRTAAATQAQANIAPQAALSLLG
>CV3878 fliC3, flagellin
MAITVNTNVSSLQAQLNLNNSQMSLTKSLQRLSSGLRINTAKDDAAGLAI
SQTLTSAIRGNNQAVNNANDGISVGQTAEGALGQIANNLQRIREIAVQAS
NGSVSNTNRSQLQNEVDQLTQEISRIVQTTQFNGTSLLSGSAVLTFQVGS
SGASSNQVSISSQDMTSAGVLCSYNSSLTATGTISVLSQGSASAILSALD
QDISQISNVRSTWGAVQNRFDAVVANLQNYVQNLTAANSRILDVDFASET
ANLTKNQILQQAGASILKQANTLPQAALTLLQ
>CV2994 fliD, flagellar hook-associated protein
MAIDFNAMPPSTWAENLARNQLSKLQTQLDTQTKSAKARTDALSQLQKAL
QDYKSSLATLTGKKSLVAMNAAATPDGMASVTAKGNAAAGNYSVFVEQLA
SSQQLLMGDLAGATAKAGDKFTVKLAGGESFDVALDGSDRDNDGKLSPSE
LALAINRASGNAGKVNAMVLNNNGVSQLVLSAGKSGEKNTISLDLSGVGD
AGLKSGLSAPKELSKAQDAVVWLGGKTNGVRLQQGSNTFDNIEGVSFTVN
KVSKDTDPPLQISVSRGDSDTTANVQSFVDAYNKVYKAITDLSQPGSNGK
PGAPFADDSSIRGLRSQLNAILRQPFDGVTQGQLGIKATRDGTLELDSKK
LGETLKATPDALDRFFNGASQNGALKQSADYLDKWLNGSNGMLKLRRDSE
DRNQKDLGRRQDALQKTFDQTYNRYLAQFTKLQSMQDQMTQTMGMLNSNF
I
>CV3137 fliE, flagellar hook-basal body complex protein
MSVNNIDQLLGELKSAAALASGKQAPAAQQTPQVDFSDVLKSTIEQVNSA
QQTSEEMQKQFQLGDNKEVNLQDVMMSLQKASLSFQTMVQARNKLVSAYQ
EIMNTQV
>CV3136 fliF1, flagellar M-ring protein
MADLAEENATPVWRARLNEAGDRFKALPNNRKILFLTALAAIFAVVVGAV
LLNRTPSYKILFSNLADRDGGQVTAALQQMNVPYQLGEGGVISVPADKVY
DVRLKLAAQGLPKASGVGFELMDNQKFGISQFAEQVNYQRSIEGELARTI
EAISSVQSARVHIATPKQSVFVREQQSPTASVMLQLYPGRMLDGGQVAGI
LHLVSSSVPNLPLKNVTIVDQDGNLLSKQAGPDENSGLDQRQLGFVRQIE
EGYVKRIEDILEPIFGRGNARAQVTANVDFSETEQTSETYRPNSSPNPSA
TRSQQISEKLVNGSANPTGVPGALSNQPPSAASAPITLPPGAAPGTANLS
GGSVSASGTLQRDITTNYEVDKTIQHTKVPTGVVKRLSAAVVVNYRRMPD
KSGEMKPTPLTPQEVQQINNLVKEAMGYNSGRGDTLNVVNAAFADNAQPV
TMQERVIDYVSGNGTSLVKYGLLGIAVLYLLFGVVRPIMRDLVRPPAPAP
GAEGEAAAAGAAGPGGRLLGVAGEEGEPGVAAAMAGGGEDPREAQKRQYS
SNLEAVRELVKSDPRMAAQIIKEWISADE
>CV2999 fliF2, flagellar M-ring protein
MAGRQLLPANAWRYLLPIVLLAIGLSVVATLWLWRDDASYKPVFGAQEKV
SGADMMAALDAEKIPYRVHPQTGQVLVPDGDLARARMQLAAKGVVAQLPA
GLELLDKNDPLGVSQFVQDVRFRRGLEGELVQSIQALDPVRSARVHLSLP
RSTSFVTAGGEKGSASVVVTLKPGQQLSSEQIAAVVKLVAGSVASLDPSQ
VTLVDQAGNLLSAHVDLSDGGIAGNNSEAARRFRDEALQNARDLLTPALG
AGNFKVSVTADVDNDRVEETREKYGEAPKVTNEASREETSTERMALGVPG
SLSNRPVNTDSSSPAADKAGNSKNAVTRQYAYDRNITNIKRARGTLRRLS
VAVALNQAAAPGGKGWQPAELANIDKLLRNGLGINAERGDVLAVSTLRFA
QPTPAEPFWEQPETWFEGARWAAYAVALLLAYLLLARPLLKLARQLAERK
LNDYTPDELDVTPDDPLLDNRPLREAASQRQAALSAAPGDSPVVPLLENY
DLPPAGSPVDVMVEHLKGLAAKEPERVAEVVKQWVQNNGRKQ
>CV3135 fliG1, flagellar motor switch protein
MSDNGIRKSAVLLFSLGQNEAVEVFKYLGPKEVQKISLAMAAINNLSYEQ
IDEVVAEFRKECDARASIGASDEYLRNVLIEALGPDKAANLLDKIMQGND
HSGIESLKWMDPSSAADLIRHEHPQIIATILVHLEPDLSSSILSFFPERM
RNEVLIRTATLEGVQPQALRELNDVLTQLLSGSDRIKKSASGGVGLTAEI
LNFMGGNVEASALSFIREYDPELAQRIQDKMFVFENLLDIDDRSIQTILR
EIQSDSLVIALKGTSTDLKEKIFRNMSQRAAEMLRDDLESKGPVKLSEVE
AEQKEILKVVRKLADDGQIVLGSKGGDEGLIE
>CV2998 fliG2, flagellar motor switch protein
MSAIEQAAVLLLCMGEEPAAAVLRCLSREELLQVTQAMSGMSGIKVDAVR
TTMQRFFDEYREQSGVHGASRSFLKRSLELALGGDIAGSVLDTIYGDAIR
PKMARLQWVSPQWLADRIAAEHVRMQAVFLAFLPPALAGQVVEALPEASR
DGVLVNVARLTDVDRELLNELDELVNRCLESLHTQSTAVEGMQQTADIIN
RLPGDRSRMMELLRAHDPEIVDEIEVRMYDFFILSRQTEEVLMRICEDIP
LEQWAIALKGAEPAVRDAIIQTMPRRQAQNFEATMRRSGPVPKSRVEEAR
REIMAQVKQLADAGEIDLQLFPEEVVE
>CV2997 fliH, flagellar assembly protein
MKHWRPFRFPPLIDGAPLAPDAAAEVQASAADGFRQGMDAGYREGFDSGE
AAGRDAGYQAGLEQGRAEGAAAARAETLAGLETLGAPLAAAIEQLNKLCR
DYQAAQRDEVVDLVAKVARQVIRCELALKPVQILDLVEETLAALPQGAHS
QGEVEVLLNPEECQRIRELAPERAAQWKLSADPSLAPGECRLRGAEFEAD
AGCQQRLERCVDSLREQLAAEEG
>CV3134 fliI1, flagellum-specific ATP synthase
MSGSLLERQRGWLAACGAAAEAASLWQPCGRLVRVTGMVMEAVGIKLPVG
SACRVMLADAHSVEAEVVGFSGDKVFLMPLTNVHGLLPGTPVLPLPSFNP
PRYGSEPGAAQAASNGAAGRQVPVGASLLGRVLDSLGRPLDGLGPIHPDA
WFPLYSQPMNPLHRTPVHDVLDVGVRAINGLLTVGRGQRLGLFAGSGVGK
SVLLGMMARFTKADVVVVGLIGERGREVKDFIENILGEEGRARSVVVAAP
ADMPPLMRLHGAAYATALAEYFRSQGLDVLLLMDSVTRFAMAQREIALAI
GEPPVTRGYPPSVFARLPQLIERAGNGEEGGGSITGFYTVLSEGDDQQDP
IADSARAILDGHFVLSRDLAEAGHYPAIDIEQSISRVMVDVVPQQQMDLA
RHFKQLYSRYQRNRDLISVGAYVSGSDPVLDDAMRRQLPMVSFLTQPMHE
SHDYASCCEQLAGVMA
>CV2996 fliI2, flagellum-specific ATP synthase
MLRQALSQLSVPDTPVATVSGKLVGVNGLLLESVGCPLQTGQRCLVETAG
GGWLQAQVVGFRREVSFLMPFKKPVGLATGARVLPAPDNGGLMIGDGWLG
RIVNGLGEPLDGKGRLGGDAPLAAHPPQINPLKKKPVDTPLDVGVRAING
FLTMGRGQRVGLFAGSGVGKSVLLGMITRHTEAEVVVVGLIGERGREVRE
FVEHALGAEGLAKAVLVVAPADESPLMRLKATELCHTIAAHYRDRGRNVL
LLVDSLTRYAMAQREVALALGEPPATRGYPPSVFGLLPSLAESAGNGEGG
AGSMSAIYTVLAEGDDQQDPVVDTARAILDGHIVLSRELAERGHYPAIDI
SRSVSRCMSQLIDADHAAVARELRGAWSRYQEVRGLLPLGAYVPGADPAT
DRALRLQPRIEALLCQDAGEAAPYAECLSRLQELASA
>CV3131 fliL, flagellar fliL transmembrane protein
MLIVIILLILVLAAVGGLAAYMFTNMNKPAGAQAEQVQEKPKKKHEGPPI
FEKMDTFVVNLAGNDGSLLQIDMQAELGDEEAKKKFADYAPKVRSAVILL
LSSKTAAEVSTAEGKVKLKAQVKQIINEAMDAGEEPVVESVLFTSFIIQK
Q
>CV3130 fliM, flagellar motor switch protein
MGDDILSQEEVDALLRGVSGEDEDDDGGQDAQGVRGYDIGRQERIVRGRM
PTLEIINERFARNLRIGLFNFLRRNAEISVGPVRVQKYSEFIRNLVVPTN
LNLVHVKPLRGTGLLIFDPDLVFLIVDNLFGSDGRYHVRVEGRDFTPTEQ
RIIHRLLEVVFTECQKAWEPVYPIEFVYLRSEMNTQFANIATPTEVVVAM
TFHIELGAGGGDFHICLPYSMVEPIRDLLSSTMQADRTEVDNRWVNLMTH
QVQAAEVELVASLAHAKVTLGQILNLKNGDVVMIEIPERVEADVSGIPVF
EASYGTVQGRYALKVEKILAGTNEFLESPGEHEQ
>CV3129 fliN, flagellar motor switch protein
MSEEELQGGAAGAEEEVSMDDWAAAMAEQETVETQHAVEAEAVPAQGLFQ
EIGAGAVAGGPPNLDMILDIPVQLTVELGRTKIAIRNLLQLAQGSVVELD
GMAGEPMDVLVNGCLIAQGEVVVVNDKFGIRLTDIITPAERIRRLQK
>CV3003 fliP, flagellar biosynthetic protein fliP
MKRALPLLPLAAAGLLAAAPAWAEPLKLLSANAGGSSVDFTIKTQILILM
TALGLLPVLVLMMTSFTRFVIVLSLLRQALGLQQGLPNRLITGVALILTL
LVMRPVGLQVWNEAMVPFDQDKITMQQALEIAAKPVSRFMLAQTGKTALA
QVARLSGEENVARPEDHAFTVKLAAFVLSELKTAFQIGCMLFIPFLVIDL
VVSSVLMAMGMMMLSPLVISLPLKLLLFVLVDGWSLTVNTLVTSIQAY
>CV3125 fliQ1, flagellar biosynthetic protein FliQ
MSPELVISIVQNALYILIIVSAPVLLTSLLVGLLVSVLQAATQINEMTLT
FIPKLLAMFLVLVLAGPWMLNTLIEYTTRLFQSIPNVIG
>CV3004 fliQ2, flagellar biosynthetic protein FliQ
MLTPDIAVDIVNDSLRVVVTLVVLLVLPSLIVGVVVSLIQAATQINEQTL
SFLPRLLIVLLTIALAGHWITGYLMDFCVAMFQRAASQVG
>CV3124 fliR1, flagellar biosynthetic protein FliR
MLAISDIQINAWVSVFAWPFARIVGLFLAEPVFAYRGVPRRFKAAFALVL
TVILAPLLPPLPAEGIAILVQQLLIGLSMGFVMRIVISAVELTGFIIGAQ
TGLGFAMFYDPVHAAQVPVLSQMLSLFTFFLFLAFDGHHVVLGALAHSFQ
VLPIGMPMPAQGIKALTLWGAHLFEWGVWLAMPIIGALLITNLAIGVMTR
AAPQFNIFSFGFPLTIMIGFCTLYLTLPMMIPVIERMYQAGFDMMLRMLQ
AK
>CV3005 fliR2, flagellar biosynthetic protein FliR
MQGLYAQLLDLVPAVWWPFCRLMAAFAIAPFIGDAVVPMRARVGLALALA
VACIPGMPAHSPIDPFTLHGVAASVEQVVIGLLFGLAFQLTLSVLALLGF
LLSSQMGLSMAIMNDPGNGNSSDVVSSLLYLLAALLFFAMDGHLVLVQVV
YASFRAWPLGGGIPQASLPVLAASVGWVMSAAMILALPVVFATFVVQAGF
GMINRVAPALNLFSLGFPVVTLFGLSTLTLLMQVLPPQYLSLSEQTLRLL
NRLLEIGHG
>CV2993 fliS2, flagellar protein FliS
MDYDAYRSYHAVNLEAQTGAASQIELVLVLFDGLLEEIARARGHLQHQRF
EQKGESISKCINILNGLSSALDFESGGEVVTNLARLYDYCAHRLYQASVE
LDAAALDEAEKLLVTLKGGWVGVRDQNAAA
>CV3810 gspH, general secretory pathway protein H
MAFAARARGFTLIEVMVVMLIIGVLATTVTLSLRPDTHRQLNDEGYRFAR
VLEQAGDLAEMGDTLALRWNGKGYAFSRLDDDGDWQPVTEELLAAHEWPE
GISGEGALLDGQPWRGERPLLLWQDGRAAALALRLDGAGRKLTVLQSPLG
RVTVADGS
>CV3809 gspI, general secretion pathway protein I
MKRQQGFTLFEVLVALAIIAVALGALLRATGLAADNAEGMERRMQANWEA
QNQIAMLQALRQFPEPGQQAGESKEDGVEWRWEREISPTPNPNFRKVVVR
ILAPGAGHYVLAEITGYLRQQAGGGG
>CV3812 hofF, general secretion pathway protein F
MAAFKYTAYDAAGKEQSGLLEADSARAARAQLRERGLLPVTVDGVSAKTG
GAGSNVLRRGLPRAELVMITEQLSTLLNAGLTLEKALTAVTEQSENARSR
TVLAALRSDILEGKGFAQALSSAPGVFSPLYRSLVQAGEQSGHLDMVMSR
LAEYLDKRQNTQQKVTLALAYPAVVTLVAILVVAGLMSYVVPQVVSVFAQ
TKQSLPFLTRALVACSDFLRQWGVALLIGIAAAAFLIVRALRAPALKRRF
HARVLKLPVFGRLFRALNTARMASTLSILVGSGVPLLTALETARGLMTML
PMQDAVADAMAKVREGVSLSRALNASRQFPPVLIHLISSGEASGTLSHML
DRAAQQQEQEVERKLATFTTLMEPLLILVMGGMVLLIVLAIMMPIIDMNQ
MVH
>CV3811 hofG, general secretion pathway protein G
MKQLKRAAQRGFTLIEIMVVIVILGVLAALVVPKVMSRPDEARIVAAKQD
IGAISQALKLYRLDNGRYPSTDQGLSALVQKPTAAPEPKNWKPGGYLERL
PKDPWGNAYQYANPGTHGEIDIWSFGADGEPGGEGNDADIGNWDSGK
>CV2628 invC, surface presentation of antigens, secretory proteins
MKPPRLLRRLANPQRLSGPILEAVLPGVAVGELCEIRRNWQEREVVARAQ
VVGFQHERAVLSLIGNARGLSREAVLQPTGRALSAWVGEEALGAVLDPTG
RVVERFSPAAAGGGEARDIDSDPPPYSRRVGVREPLATGVRAIDGLLTCG
VGQRVGIFASAGCGKTMLMHMLIEQADADVFVIGLIGERGREVTEFAEAL
RGSDKRDRCVLVFATSDFPSVDRCNAALLATTVAEYFRDQGKKVVLFVDS
MTRYARALRDVALAAGEPPARRGYPASVFDSLPRLLERPGATGAGSITAF
YTVLLESDDEPDPMADEIRSILDGHIYLSRKLAGQGHYPAIDVLKSASRV
AGQVTDTGQQQAAAAVRGLLARLEELQVFIDLGEYRPGENADNDRAMSLR
DPLRRWLRQRMDERAAYRDTLESMDGFRA
>CV2632 invG, invasion protein- outer membrane
MNKHLLCALLSGCAVLLAQPAASAPQAAESSGYVAKKDGLRGFFDALSSR
LKKPVIVSKLAARKQISGEFDLANPQAMLEKMAQQLGLIWYHDGQAIYVY
DASETRSSIVSLRNVSLQAFNDFLRKSGLYDKRYPLRGDGRSGTFYVSGP
PVFVDLVVNAASMMDKQSDGLELGRQKIGVVRLGNTFVGDRTYDLRDQKI
VIPGMATVIEKLLDGERKPVAGLAPPAAEKRDDIPAMPDFKEGRGLPYQA
GLSLPEALKRDAAAGDIKVIAYPDTNSLLVKGTAEQVRFIENLARALDVA
KRHVELSLWIIDLQKDDLDQLGVNWSGSVTVGNKLGVTLNQAGSLSTLDG
TRFLAAVMAMTSKKKANVVSRPVVLTQENIPAIFDNNRTFYAKLEGERSV
DLQHVTYGTLISVLPRFAADGQIEMSLSIEDGSQARAPDYSSDNKDAGLP
EVGRTRISTVARVPQGKSLLIGGFTRDASERGEGKVPLLGDLPLVGGLFR
YQSAKQTNTVRVFLIQPREIDDALTPDASDLSADLVRRAGIETDPLQQWV
RNYLDREQQDK
>CV2989 lafT, chemotaxis lafT protein
MQQLFGILIVLVCVFGGFMLHGGVLSIIWQPTELLIICGAALGAVVLGNP
PHVLKEMGGQIKRVVVRKKQGAEFQRQQLLLMYELLITASRGLKALDQHV
EAPRQSPLFNRYPMVLENRKLLAFIVDNFRLMAMGKINAHELEGVLDQEL
DAIHEQLMQPSKSLHKIAEAMPGFGILAAVLGIVMAMNTVAQGASAGEIA
ASVAAAMVGTFIGIFFCYGVLDPLSNVMHQLVKEELSNFESVKVVLTTHV
SGKPPLLAIDAGRRLVQLNTKPSFSQLESWINAMEGLG
>CV2988 lafU, chemotaxis lafU protein
MAGLKNKGEHDGAVIKKVSRRNAEEGHGGAWKVAFADFVLALMCLFLVLW
VLAARDQENLQQLLTTSGGSPLLQGNGKQIDHMGNPPGTLIPRDPIPGQA
GSQAASKSAVRDSDKRASEQPELPRRSYDSEADLRKLAAQLSEMSQKAGL
SSNLQTVITPYGLRVTLHDTDQQGMFERGSAIVEPRFRSLLQQIGSMLGE
IDNRLLVVGHTDAAQYHRAGGFAAMSNWSLSSNRAMAARLHMMQGGLAAD
SVLQVVGMAERAPLDKQHPLGAVNRRIELLVLTSGQAQAVVAMFGARGEG
LANAPGVALALPNAEDLKTLRENTINMQ
>CV2026 motA1, chemotaxis motA protein
MFVGIGYLIILGSVLGGFIAAGGHVAALMQPLEVVMIAGAAIGAFIVANG
GAPLKATTKALPTVFKGSPYGKAFYMDLFSLLFEILTKVRKEGLMSIEAD
VENPEASPVFSKYPTIMHDHHVVEFICDYLRLMVGGNLNAFEIENLMDVE
IETHHHEGEVPVSAVKGLADGLPAFGIVAAVMGVVHTMESVGAPPSELGM
LIAHALVGTFLGILLAYGFVGPLGTILEHKLAEGTRVYQTIKVTLLASLN
GYAPQVAVEFGRKALSSMDRPSFKELEDHVKQKK
>CV1021 motA2, chemotaxis motA protein
MDKISLIAIVMGLTAIIAGQAIEGGSIGSLMQLTAFMIVIGGTTSAVMLQ
STPKQFMAGLRMLRWIFRPPNFDHEKMIREVINWSQTSRKGGLLALEGLI
ATQRDPFTKKAMQMLVDGTEPDTLRAVMEVEISMFEHARRQAARIWESAG
GYAPTMGILGAVLGLIHVMENLSDPSKLGGGIAVAFVATVYGVGSANLFF
LPMANKLKHLVASELAMKELVVEGVVAIANGENPRIIESRLRGFLAMHE
>CV1814 motB1, chemotaxis motB protein
MASRRRKQEEEHENHERWLVSYADFITLLFAFFVVMYAISSLNEGKYRVM
SSAIMDAFRSGTTITVQTTPPTGGANTMIEIPQTKPIAKSTARNRKAEEA
AKLGQLTQNLAKALSPLVQSGEVTITQSNQGIHIDIRDSALFAVGQAVPN
QQSMPLMSNMAKLLAGVDNAIKVEGFTDDAPIRTPVFPSNWELSAARAGG
VVRLFQESGVDPQRLVAVGHGANQPVADNATADGRARNRRVTISVQANTF
EEPAAENAAPAAKAPGNHTPTPTEVRP
>CV2027 motB2, chemotaxis motB protein
MADESQRPIVVKKIKKGGHGHHGGAWKIAYADFVTAMMAFFLLMWLLGSA
SQGTLNGISEYFKTPLKVALSGGAGAGDATSVIKGGGNDITKQAGQVNKA
GAKQEEVMQKQKEQARLNQLQQKIQQTIDQSELFKQYKNQLKLEMTPEGL
KIQIVDEQNRPMFDSGSSRMLPHTRVLLQQLAPELNQLPNRISISGHTDA
KPFGGGQGGYSNWELSADRANTARRELVAGGLTENKILRVVGLASANPLI
KSDVFSPENRRITIVVLNKDTESSILNDGFKPQMNQDVIGGPSEGAAPAA
PQQGEP
>CV1417 nahY, methyl-accepting chemotaxis transducer protein
MISFLAQFSIRAKIFGLIVLGVLAALIIGFNGISGASSMFDLTRDMHDNA
LKPVYLLGQAAKQAAYVNRADYRYIAESEKKEMDQVQVNRDKFSAAMKGF
LDQYRQTQLTPPEVDGLKRFDAAWAAMEGPCKQVRDLSYTDTGNGENNKK
ALAIMSKQCRPLFQAADDVLTELSNINIKLADKSLEDAQGKYQALRTMSI
TVLVVGLVVLTALGLAIQNGIIGSLKEACRAMEKMGGGDLTGDIKAQGRD
EVADMMRSLSDTQIRLRNTVGEIIRSAASVAATSEQLAASTEQVSASIGQ
QVNATSSAAASIEELTVSIDLCASNAGQANEQAAEAGQQAKAGNKDVQDS
TTRVKRVNESVTSSADSLESLSDQAQQIGSIATVIKDVADQTNLLALNAA
IEAARAGEQGRGFAVVADEVRKLAERTTSSAQEITNMIGKIQDGAREAVD
GMRSSRQIVADVVVAAENASATISTVEERAAGVVSVINEIALAVGEQRQA
STELAGRVEAIAQMSKENGIAVDVFSQATRELAMVAEKLQQTTLAFRME
>CV3828 pilB, type 4 fimbrial biogenesis protein
MEATAGISGLGRALVQHNMLLQQDADAISKQATTSHLSFVEQLIQSKKMT
SRDIAMFSSRVFGYPLLDLASLDTEQLPKGLVDDEVIASRRLLPLLKRGN
KLYIGTSDPTQTSAYHAITFKTGLTVEVVVVEEDKLSKLIGRYQDNSTSA
LKELESEDFGDLEFADPDAQLDSGPQTEVDDAPVVKFIHKMLLDAIGIGA
SDIHFEPYEKYYRIRYRVDGVLKEVAQPPLLLKEKIASRIKVISRLDISE
KRLPQDGRLKLVISKTRAIDFRVSTLPTLYGEKIVMRILDSSGASLDIDQ
LGFEPEQKAHLLKAIARPYGMVLVTGPTGSGKTVSLYTCLNILNKPDTNI
STAEDPVEINLPGINQVNVNEKAGLTFASALKAFLRQDPDVIMVGEIRDF
ETADIAIKAAQTGHMVFSTLHTNDAPSTLTRMLNMGVAPFNIASSVLLIM
AQRLARRLCSHCKQPVEIPKEALLRAGFTKEDLAGGWHPYGPVGCEECRN
TGYKGRVGIFEAMPISDAMMRLIMKNGTSVDISDLAKEEGMVDLRRAGLL
KVMSGVTSLAEVEAVTND
>CV3827 pilC, fimbrial assembly transmembrane protein
MATTAAKKANPGYIWEWEGKDKSGKMIRGELRAESEAVAKTQLRRQGINV
AKIRRRRSGFGKKITEKDITLFTRQLSTMMRAGVPLLQAFDIAAKGHSNP
AVTRMLLEVRADVETGLSLAEAFRKRPLYFDKLFCNIIAAGEAGGVLDTL
LDKLATYKEKVMAIKSKIKSAMIYPSAIVGTAFIITAVIMIYVIPAFKDL
FSSFGANLPAPTLFVIWLSDQFVHFWWLIFGTLFGAIFAFFYAFKRTPKM
QEQMDRILLRLPVIGDIIRKATIARWARTLSTLFSAGVPLVEALDSVGGA
AGNQVYAEATRRIQADVSTGSSLNYSMQRTDLFPNMVLQMTSIGEESGSL
DQMLDKVADFYEEEVDNAVAALSSLLEPAIMVILGILIGGLVIAMYMPIF
KMGQVVG
>CV3116 pilE1, type IV pilin
MKKKPEGFSLLELVIALAVLALLVSIALPSYRSFMMQSNRTAAKTALQDL
ASREESYFAINNNYASQLATLGYASGTVYVPGSGNNLYALSIASATNSTF
VLNAAPQGSQAQDSCQTYQLDNLGNQSNIANGSSGTPLNVSGCW
>CV4209 pilE2, type IV pilin
MKKQRKQQGFTLIELMIVVAIVGILAAIAIPAYQDYTKRARVSEGLALAD
AAKTAVTEYYATNNAWASGTAPFNTTYGLAASITGNSVSSINVLANGVVQ
IAYNSTVSNGALVDLVPTVSAGSVQWYCTYTGSGTTAIASASQLSANWVP
STCRQ
>CV0483 pilE3, type IV pilin
MRGVTLVELMITLAVVAILGTIAYPMYTGYAQRSRRSDAWQALTTAQAQM
EQCYSQYFAYNNAACTVTTASPNGYYQVQIASSTTASAYTLTATPVSSGL
QAADTSCGSFSVGSTGIRSAQNAQGADTSSTCWPH
>CV0833 pilM, type 4 fimbrial biogenesis protein PilM
MLVDKLRLGRSLLEQLGLGKSHNSPLLGLDISSTAIKLVELSRNGRNIQV
ERYVIEPLPKDAVNDGNLVDIEGIAEALRRGWKRLGSPIRSVAIAIPTPM
AIYKKLLVPASQTEDMDELIESEANQIIPFPLDEVNLDHQVLGPSPSSMD
DLEVLLCAARKEKVEERVAVVEMAGLRAHVVDVESFAMMTAFEQIQQQLP
EEGMNQTFALFDIGATRIHCNIIRNNQQIYYREQMFGGHQLTRDVQRRYN
VSFEEAESGKRSMALPDGYESELMHPFIDSLAQEIQRALQFFYTTVSVSQ
YLRVDYILLAGGCSMLPGLDDAVAGRSQISTMIANPFTTLVQAPGIRLKE
LLMDAPSLLIACGLALRRFD
>CV0832 pilN, type 4 fimbrial biogenesis protein PilN
MIRINLLPHREQKKAAHRLRFQLMLGATVLASLLLLTIGYLTLQHQIAGQ
EARNLFLQKEIGKLDRQIKDIGKLKKQRDDLLARKQLVERLQEGRNSAVH
LFDQLVRQTPDGVYLKSFKQTGNQVTLTGYAQSGARVSSYMRLLGQSETF
DAPVLVEVSSSIVNNQRVSAFTLNAGIRQSPPANKPAGATP
>CV0831 pilO, type 4 fimbrial biogenesis protein PilO
MDELRALDPKDMPNWPLQAQGLMMFLLLLLVVGLGYFFVLGEQLDKLNQS
RQQEATLKQTFVDKKRQAVNLDALEQQLKEIDASFGALLKQLPTKSDMDT
LLTEINQAGIGRGLQFDLFKPGGETRTAEMAEVPITLRLTGTYNDLAAFV
NDVAQLSRIVTIGEISLTPTSGNRLTMDATARTYRALEPGERMSVQAQK
>CV0830 pilP, type 4 fimbrial biogenesis protein PilP
MRTIAICLLPLLLSACGDNSSEDLKQWMANSSLGLRGQIEPLPQVQTYKP
FNYQAYDLTDPFNPQKLQAGKQQNAANAPDLKRPREALENYDLDKLAMVG
TIRRGGAVYALIRTPEGAVYRVQPGNYLGLNFGKITSISDAEVQLAETVE
DLNGEWVQRSSGLHLEEQGQNK
>CV0179 pilT, twitching motility protein PilT
MEISELLAFTVKNKASDLHLSAGLPPMIRVNGDIRRINLPPLDHHDVHDM
VYDIMNDYQRKTFEDTYECDFSFELPGIARFRVNSFIQNRGMASVFRVIP
SKVLTLEQLSAPRIFQDIANYPRGLVLVTGPTGSGKSTTLAAMIDYVNEN
AFSHILTVEDPIEFVHESKKSLINQRELGLQTHSFANALKSALREDPDVI
LVGELRDLETIRLALTAAETGHLVFGTLHTSSAAKTIDRIVDVFPAGEKE
MVRSMLSESVRAVIAQTLLKTKDGQGRVAAHEIMIGTPAIRNLIRENKIA
QINSMIQTGQQHGMQTLDQCLADLTRRNIVSPAEARAKASHKDAF
>CV1458 pilU1, twitching motility protein
MLMLPFFKLMAEKKASDLFLTSFSPPMLKLGGELTPVNEKPLTPDMVKQL
AYSLMSEEEAAVFEREREMNLGHPVPGLGSFRVNVFWQRGSVGMVVRYIL
PSIPTVEELQLPPLLEELIKLKRGLILVVGSTGSGKSSTVAAMLQSRNRS
MKGHILTIEDPIEFLFRHDQSIVNQREIGFDTLSYARALKNAMREAPDVL
MIGEIRDPETLSQAIGYAQSGHLCISTLHGNNSYHMLNRVMNFFPAEARG
ALLMDLSASLRAVISQRLVATLDGGRVPALELLINTPHISELIRAGEMDK
IKEAIESSMSDGAQTFEQALFQLYQAGRISLDEALKNADSPTNLYWLINQ
SQEAGKGKDKPGPASAASFDSIKLDL
>CV0180 pilU2, twitching mobility protein transport fimbria
MEKDQASKFIHDLLKHATGKNASDIFIAAEFPPAMKIDGKITPVAPQALT
ALQSKELVRAVMNDRQTEEFEAKKEANFAINPPGVGRFRVSAFVQQGMVG
MVLRKINTEIPTFDQLNLPEVLKDIALIKRGLVIFVGGTGSGKSTSLAAL
VDWRNSNNQDHIITIEDPIEYVHTHKKSIVTQREIGVDTENWEVALKNTL
RQAPDVILMGEIRDRETMAYGLQFAETGHLCLATLHANNANQALDRILNF
FPEERHQQVLMDLSLNMRAIISQRLVPHKSGRGRVAAVEILLNSPLVSDM
VFKGEIAGLKEVMGRSREAGMQTFDQSLFELYEAELITYEDALRNADSIN
DLRLRIKLYSESARNRDPLEGIDHLDIV
>CV3112 pilV, type-4 fimbrial biogenesis PilV transmembrane protein
MSMSAPRQSGFSMLEVLVALIVISLGLLGIAGMQAAAINSTSIARSRSLG
AIAAQSMAAAMHANTAYWGALSASGSWSVSASGVISGTPSLSQTVVCSAS
GTTCTAANIAGYDATQWGSGTISALPGGSGQIACNPASSATPVVCTITVY
WLEKSRSVNAASMTAATASQSYQMVVVP
>CV3721 pilZ, type 4 fimbrial biogenesis protein
MDAANHRPDLNNPNRPGVLSLHIKERSALFAAYMPFLRNGGIFIPTNKEM
QLGEEVFLLLTLMEDPQRIAVQAKVVWITPGGANNSRVQGVGVEFVSGEA
GKQAKDKIEALLGGVLNSSRPTHTM
>CV2606 pscQ, translocation protein in type III secretion
MSFNHREAGPGLSLIAQLDDQPVRLWMAEAQWLQWVEPMLSLPSWDMAPP
DLRELLAVWTLADAGSGLDDLGLPWPQATRLEPEPIDAGMGWRLRILRDE
RQLDLLVRDAPQSWLDAVAEQAYPIEMDETETAITAGVSLIAGWSMVEMA
SVRKLVVGDALLLRYSFDVAAGKFGLFNRQPIASLMQDGETGIFTVETLM
SDFEDWMDITPTLSPAEEQALGDAMITVTVEVAKMELPLHQLGNLQPGTL
LSSAVSSDGLVTLKAGSRPIARGTLLDIDSRLAVRIEHLC
>CV2619 sipB, cell invasion protein
MSDASAISRSAYLHNPKLAETAFESVRKDGTFLDAADKALKAVLATKAGE
ADGKAPIRERDLATPALTQPTAKAKEELDGAGKLTLLLGQLMSLLGNVSL
SQLESRIATWRAMMEAQVAMGEKLSQEFQDAFKAASEATEALKDAVGNYD
SAKQAADAAQKKADAAQAKVDGMSPDEPGYAEAQAASQQAAADALQAKQK
ADKAYDAAEKARVVAVEKGKVADDLAGKVQGANVNADVARKTGEDNLSNV
AKLTLLMAMFVELVGKNSEESLKNDLALFQALQEGRQKEMDKKSAEYQEE
VRKAEELNRTMGCIGKILGALLTVVSVVAAAFTGGASLALAAVGVALMVA
DEVVKAATGVSFMQEALKPLMDKVLKPLMDLIGKAITKALEGMGVDKKTA
ELAGSIAGAVLAAVAMVVVMVVVAVVGKGAAGKLGGALSKLLGDAIKKIV
PNVLKELAKGGSKMLTQGFQRLANSLGLQTDAAAKQMMANTLGRVVVGGE
VAQATSQAGGNVAQGVFMKNASDALADFTLARAAMEQIEQWLKQAVEVFA
STQKVTQELTTAMSAAVQQNAEAGRFVLRQSHA
>CV2625 spaO, surface presentation of antigens; secretory proteins
MRLALRQVDGAALALRRCGEAWAGQDVRIAYPPSHGCWLKVAGADGSWQG
WLQPRAWLRHMAPELASLASAAGMDDRLSELIAACEAPLSWPVADMPLGR
IVAGERREGSQLPQRPMLRMDTPQGEVWLEKAPAPAEAARDRVPGWLPMP
LRFLLGDSMVSPSLLRRAKAGDVLLISRPAQTVSCNGRAIGTYQWTEEGI
IMEWQNEMAAAAETRPLADLDRLPVRLEFVLQQSEVTLDELRELCRSNVL
PLSADAERRVELRANGALLGRGELVQLDGRLGVEVAQWLGGSGDVE
>CV2621 spaS, secretory protein / flagellar biosynthetic protein flhB
MSSNKTEKPTRKKLQDAAKKGQSFKSRDLVVACLTLCGVAYLVSFGSLVE
LMGIFRQALAGGFQLDMRGYAQAVFWQGLKLLLPIFLLCVAASALPVLLQ
TGFVLASEALKLNLEALNPINGFKKLFSLRTVKEAVKALLYLASFVVAVA
LIWRKHKALLFAQLNGSVMDIAAVWRELLLSLVLTCLGCIVLILILDALA
EYFLFMKDMKMDKQEVKREMKEQEGNPEIKSRRREAHFELLSEQVKSDVE
NSRLIIANPTHIAIGIYFRPELVPIPFVSVMETNQRALAVRAYAEKVGVP
VVRDVPLARRILASHRRYSFINLEEVDEVLRLLEWLEQVENAGRPDDEPS
GGP
>CV0627 tap, methyl-accepting chemotaxis protein IV
MRNLSIAARITLGFGLLLAALVLTGVLTQLGLNKISSRVAEVSSHELVFY
TDIVDLQRGMGNLRRFEKDYLINIASDAKRAEYLGKWKDALAGAQKAIQQ
ADTHPLDDGAKQKLAKLGALLSGYADGFGKVSAQVEARQLTATADANKEL
DKYKENIHQMEGVSAELAKAAADAVGLLDDQIDATASAVRAQLMTEIIIA
LAVGALFAWYIISSIRQPLLKMRDASQELADQRNLRLQLPDFGRNELGSV
AGSLAKLVDSVRAVVVESQQHSASLAQAAGQLSGVSDHVSSASVHQSEAA
SSGAAAIEQMSVSINLVADSTQDVERQARLTMEQATAGSELAQKAAGEIR
QIATSITETSTMMDGLNQRSADIGDIVRVIHDIADQTNLLALNAAIEAAR
AGEMGRGFAVVADEVRKLAERTSQATTEISSHIDGVLADTQRAYHSMQQA
NSRIESGVVSASSVADALLQIRDLAAQSVQRIADIANAIKEQSQASQSVA
RNVEQIAQMNGQTTEAATEASKLATELSSLSEELDACLQRFRT
>CV0031 tar, methyl-accepting chemotaxis protein II
MIATIKGKILVGSGLLILIGFTVLAGANIYNSYRNAESAVLEHARLLAGS
EAGRVQRMLGKTYDSAQAMAEAAVGVKAALPANGRALLSEVVKRQLPNNP
DAVGYWVDWEPNAFDGRDAELAGKPENDHTGRYGVYWFRKAGKVDVVWGS
DGVDESAYYTEPRKTGKPMLTEPYVDPDVKILMGTLSFPLNIGGKVLGVA
GCDIALGHLQEMAAKVRPYDAGFMSLYSNGGVQLAGRQPGLNGKPAPDLP
AEAKAAIKDGRPAEYRSDDGFRHFIMPIVVGEAGTPWAVRISIPEDEAFA
PVRAASWQSALISLGILALILLLLGTTLNQLLRPLGRLQGAMTELASGSG
DLTRELSIASRDEIGQAAGAFNTFTGSLRRMMLDVRGHAGDMLGSVRQLT
GDVGQIRDSSARQSQAANATAASVEQLSVSVTHIAESARVAEQRAREADA
LSSQAAANVDATAAEIGRIAHTVRQLADVLGGMQQRSDRISGIVSVIRDI
ADQTNLLALNAAIEAARAGEQGRGFAVVADEVRKLAERTAQATLEISDVI
QTMQKDTSHAADSMSGALEQVEQGVKLAGESSQSIQQISGQAQQVVHAVG
DIAVSTAEQSSASQEIARHIENIHGMLLQTDDSIHQAQQATVALARLGEE
LESLIGRFKL
>CV4297 trg, methyl-accepting chemotaxis protein III (MCP-III)
MFPYPRVSKMQLNTRLIIIIAASLLALLGLSTTALLSTRATLHQEKRDQI
VHLLKMAENSLTHFQQLEAKGMPRAEAQKQAIAALSALKVDDIYFFGRNR
EHRVLFHPSKDRVGKLDMGSKLPDGRSTVEAYDDAMKDAHYGVLVIQTKR
KGSGDQEFPKLNGVFRFEPWDWTIGTGIFIDDIDQLFWSEARTLMAVAAI
CVVVLGALVGWMSRSILQSLGGEPRYAANVVKAIADGDLSLEIQVKGGPD
SLLGAMNDMRGKLRQMIDEIGRATSSINHSCHQLSSDMDKVHEVSGIASS
STTSAAAAIEQLSVSIDHVSASTRDTETGARDTAELARHGKNLAGDAANG
IRQIADQIHGASDMVGQLAERSRSISSIAETIRDIANQTNLLALNAAIEA
ARAGEMGRGFAVVADEVRKLAERTASATDEISNIVQAVINETGNVSGRMD
EIRPAVQAGVEQVHQAAETLESISQQATTALEHVHNVVVAMGEQSQAGTN
IAGNVEQVAGVVEETQNSVSHAVEAVRAIDQQASNLHQTVSRFRL